Louisiana State University

LSU Digital Commons
LSU Doctoral Dissertations

Graduate School

2004

The effect of beta-carotene vitamin E, and vitamin C
supplementation upon work capacity during a protocol of arm curl
exercise using the Biodex dyanamometer
Ivan Kenyon Guillory
Louisiana State University and Agricultural and Mechanical College

Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations
Part of the Kinesiology Commons

Recommended Citation
Guillory, Ivan Kenyon, "The effect of beta-carotene vitamin E, and vitamin C supplementation upon work
capacity during a protocol of arm curl exercise using the Biodex dyanamometer" (2004). LSU Doctoral
Dissertations. 632.
https://digitalcommons.lsu.edu/gradschool_dissertations/632

This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It
has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU
Digital Commons. For more information, please contactgradetd@lsu.edu.

THE EFFECT OF BETA-CAROTENE, VITAMIN E, AND VITAMIN C
SUPPLEMENTATION UPON WORK CAPACITY DURING A PROTOCOL
OF ARM CURL EXERCISE USING THE BIODEX DYANAMOMETER

A Dissertation
Submitted to the Graduate Faculty of the
Louisiana State University and
Agricultural and Mechanical College
in partial fulfillment of the
requirements for the degree of
Doctor of Philosophy
in
The Department of Kinesiology

by
Ivan Kenyon Guillory
B.A., Morehouse College, 1993
M.S., Louisiana State University, 1996
August 2004

Acknowledgments
My sincere thanks and appreciation go out to my major professor Dr. Arnold Nelson for
his support, guidance, and patience during my matriculation at LSU. His boundless insight was
extremely helpful during the development of this study.
I would also like to thank Dr Michael Keenan who, as the nutrition expert on my
committee, lent his expertise and wisdom toward the development of this project. For this I am
forever grateful. I would also like to thank my other committee members: Dr Robert Wood, Dr
Dennis Landin, and Dr Fakhri Kareem Al_Bagdadi for their guidance and input towards my
development as a scholar.
Thirdly, I would like to acknowledge the assistance from Dr Jennifer Rood at the Clinical
Chemistry Laboratory at Pennington Biomedical Research Center. Without the help of she and
her staff, the serum analysis would not have been possible.
I would also extend my gratitude to my fellow graduate students, present, and past who
have shared my time here and have lent their support through constant encouragement and
camaraderie: Christopher Davis, Rhonda Prisby, Michael Crutcher, Pamela Aaron-Ratliff,
D’Nais Jones-Mack, Kim Chavis, and Gerald Thompson.
Finally, I would like to acknowledge my family: my father - Ralph Guillory, my mother Elaine Allen, my stepfather - Tyrone Allen, and my sister - Lorin Guillory. Your unending
support and encouragement are what brought me through this process. You have no idea how
many times you have encouraged me to continue to press forward. For this I am forever grateful
and I love you all.

ii

Table of Contents
Acknowledgments..............................................................................................................ii
Abstract...…........................................................................................................................v
Chapter 1 Introduction / Review of Literature.....................................................................1
Function and Role of Beta-Carotene........................................................................4
Recommended Dietary Allowances and Toxicity....................................................6
Beta-Carotene Supplementation and Exercise.........................................................6
Function and Role of Vitamin E..............................................................................7
Recommended Dietary Allowances and Toxicity...................................................10
Vitamin E Supplementation and Exercise...............................................................11
Function and Role of Vitamin C.............................................................................15
Recommended Dietary Allowance and Toxicity....................................................17
Vitamin C Supplementation and Exercise...............................................................18
Antioxidant Combinations..................................................................................….22
Prooxidant Activity of Beta-Carotene, Vitamin C, and Vitamin E.........................25
Muscular Fatigue.....................................................................................................29
Summary..................................................................................................................33
Main Points..............................................................................................................37
Project Rationale......................................................................................................37
Preliminary Studies..................................................................................................38
Problem Statement...................................................................................................39
Objectives.................................................................................................................40
Hypothesis................................................................................................................41
Limitations / Delimitations.......................................................................................41
Chapter 2 Methods..........………........................................................................................44
Subjects...................................................................................................................44
Supplementation Protocol.......................................................................................44
Exercise Fatigue Testing Protocol..........................................................................45
Blood Analysis........................................................................................................46
Data.........................................................................................................................46
Power Analysis.......................................................................................................46
Statistics..................................................................................................................47
Chapter 3 Results…..........................................…..............................................................49
Subjects..................................................….............................................................49
Food Diary Measures..............................................................................................49
Serum Vitamin C....................................................................................................50
Arm Curl Exercise Measures..................................................................................52
Chapter 4 Discussion................................................…......................................................56
Food Diary Measures.............................................................................................56
iii

Serum Vitamin C.....................................................................................................59
Power and Significance...........................................................................................60
Acute Supplementation Work Values.....................................................................61
Chronic Supplementation Work Values in Untrained.............................................61
Chronic Supplementation Work Values in Trained....….........................................62
Main Effects and Interactions...................................…...........................................62
Antioxidant Status........................................................…........................................63
Limitations and Other Concerns....................................….......................................64
Chapter 5 Summary and Conclusions..................................................................................68
References..........................................................................................………......................70
Appendix A: Food Diary Questionnaire.……….................................................................79
Appendix B: Pilot Study Data and Power Analysis for Sample Size....………...................83
Appendix C: ANOVA Statistics Dissertation Study.........................................……….......91
Appendix D: Consent Form........................................................................………..............93
Appendix E: Power and Statistical Significance........................................………..............97
Appendix F: Obtaining and Motivating Subjects.........................................………...........105
Appendix G: Journal Article.............................………......................................................108
Vita...............................................................................………...........................................120

iv

Abstract
The effect of acute and chronic supplementation upon work capacity in trained and untrained
subjects was examined using 10 normal healthy subjects (ages 19-23). The subjects were tested
using a double-blind crossover design. During the two supplemental stages subjects ingested
either the placebo or antioxidant mixture capsules (beta-carotene, vitamin C, vitamin E). There
was a 28 day washout period between the two supplemental stages. Subjects were tested during
each stage for an acute effect (one day of supplementation) and chronic effect (twenty-eight days
of supplementation). Testing consisted of seven sets of arm curl exercises with a 60-second rest
period between each set. Work, during the last three sets of each phase, was recorded and
compared for each subject. Hypotheses tested was whether an acute (one day) and chronic (28
days) supplementation protocol would have an effect upon work capacity in untrained as
compared to trained subjects. No significant differences were seen after acute or chronic
supplementation in either trained or untrained subjects. However, power for the study was too
low to make a determination without a high risk of Type II error. Significant subject dropout and
work measure variability contributed to the low power.
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Chapter 1 Introduction / Review of Literature
The recent interest in antioxidants and free radicals has prompted an increase in the
supplementation of these substances by many in the general public. Athletes believe that
supplementing their diet with antioxidants helps to maintain optimum fitness. To this end
vitamin manufacturers market antioxidants to athletes, professional and amateur alike, as an
ergogenic aid counteracting the affect of oxidative stress during exercise (Urso and Clarkson,
2003; Applegate, 1999; Juhn, 2003; American Dietetic Association [ADA], 2000). It is well
accepted that exercise causes an increase in the production of free radicals and other reactive
oxygen species (ROS) (Powers and Hamilton, 1999). Among these ROS are O2- (superoxide
radical), H2O2 (hydrogen peroxide), and OH (hydroxy free radicals). A proliferation of these free
radicals can cause a decrease in the function of affected cells and can result in a decreased ability
of muscles to maintain work. Some may believe that the ingestion of antioxidants will help to
stave off this proliferation of free radicals during exercise and thus provide a beneficial effect.
Vitamin E, vitamin C, and beta-carotene are three antioxidants that have garnered the
most attention from those who wish to supplement their diets with exogenous nutrients. Vitamin
E works to protect cell membranes by breaking the chain reactions that attack the lipid portions
of those membranes. Vitamin C works in conjunction with vitamin E and is located in the
cytosol of cells. It helps to regenerate vitamin E that has been used to fight the lipid peroxidation
occurring within cell membranes. Beta-carotene is a form of vitamin A called pro-vitamin A. It
can be converted into vitamin A as needed by the body, and much of it is located between the
lipid bilayers of cell membranes. In this position, it also acts as an antioxidant protecting cell
membranes.
During strenuous exercise, there is an increase in oxygen uptake by working muscles. As
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work intensifies, oxygen uptake increases. This increase in oxygen uptake results in an increase
in ROS that may result in the fatiguing of working muscles (Powers and Hamilton, 1999). A
study by Reid and Shoji et al (1992) tested the muscle fibers of rat diaphragm in vitro to
determine if, while working, these fibers produced an above normal increase in superoxide
radicals (O2-). Fibers were bathed in a Krebs-Ringer solution containing cytochrome C and
stimulated artificially (550 mA, 13 V) for one hour. Afterwards, measurements of O2- were taken
at an absorbance at 550 nm using a spectrophotometer (model 260, Gilford). Repetitive tetanic
contractions resulted in an increase in absorbance of 400% relative to relaxed controls,
indicating an increase in O2- release in active fibers. Addition of superoxide dismutase to the
medium resulted in an inhibition of this increase in absorbance. This confirmed that O2- was
responsible for the increase in absorbance. Davies, Quintanilha, Brooks, and Packer (1982)
exercised rats to exhaustion on a treadmill to observe the magnitude of increase of free radical
concentration. The male Long Evans rats were exercised at a sub-maximal work intensity level,
and immediately sacrificed. Using the electron pragmatic resonance (EPR) spectroscopy method,
researchers found that there was a two- to three-fold increase in free radical concentration in
muscle and liver, immediately following exercise.
The human body has adequate antioxidant defenses under normal physiological
conditions. These defenses include enzymatic and nonenzymatic antioxidants within the interior
and exterior of cells. The non-enzymatic include antioxidant vitamins, uric acid, glutathione,
alpha lipoic acid, bilirubin, and ubiquinones (Powers and Hamilton, 1999). Enzymatic
antioxidants are located mainly within the mitochondria and cytosol, and include superoxide
dismutase, glutathione peroxidase, and catalase. The functions of each of these antioxidant
molecules are illustrated in tables 1.1 and 1.2. It also appears that the body can make adaptations
2

in enzymatic antioxidants depending upon the oxidative capacity of muscle tissue. Jenkins,
Friedland, and Howald (1984) have shown in the past that, superoxide dismutase and catalase
show a linear relationship with respect to VO2 max. In a study in which 12 healthy subjects had
their VO2 max as well as, superoxide dismutase, and catalase activity measured (in the vastus
lateralis), it was discovered that those subjects with a high aerobic capacity (defined as VO2 max
over 60 ml/kg/min) had significantly higher levels of both antioxidants, than the subjects with
lower VO2 max. This suggests that the human body will adapt to a change or difference in
oxygen consumption and the possibility of a higher than normal influx of ROS in to muscle
tissue.
In another study by Robertson, Maughan, Duthie, and Morrice (1991), blood antioxidants
were measured in six untrained and 12 trained subjects (runners). Twelve runners were assigned
into two sub-groups - a high mileage group (80 - 147 km/week) and low mileage group (16 - 43
km/week). Results showed that plasma creatine kinase activity was significantly correlated with
weekly training distance, indicating that there was muscle damage. The erythrocyte activity of
glutathione peroxidase and catalase was significantly and positively correlated with the runners
weekly mileage. This suggests that endurance training may increase blood antioxidant defenses.
During times when ROS is above normal, such as during prolonged exercise, or when
antioxidant defense is hampered by nutritional deficiencies, the increase in free radicals may
cause cell damage (Ji, 1994), decrease endurance capacity by as much as 40% (Davies,
Quintanilha, Brooks, and Packer 1982), or attenuate force production by as much as 20% (Reid
and Haack et al, 1992). Because of the recent emphasis on antioxidants in the diet, and their
connection with optimum health, many individuals have increased their intake of these
molecules through daily supplementation of multivitamins. Chief among the ingredients of most
3

multivitamins are the antioxidant vitamins E, C, and beta-carotene.
Function and Role of Beta Carotene
Beta-carotene is a pre-cursor vitamin A referred to as pro-vitamin A. That is, the human
body can convert beta-carotene to vitamin A as needed. It is essentially composed of two
molecules of vitamin A joined together (Guthrie and Picciano, 1995). It also belongs to a class
Table 1.1 Functions of Enzymatic Antioxidant Molecules
Enzymatic Antioxidants

Functions

Superoxide dismutase

Catalyzes the conversion of two superoxide
radicals (O2-) into hydrogen peroxide and
molecular oxygen

Glutathione Peroxidase

Eliminates hydrogen peroxide and organic
hydroperoxides

Catalase

Eliminates hydrogen peroxide

Table 1.2. Functions of Nonenzymatic Antioxidant Molecules
Non Enzymatic Antioxidants

Functions

Vitamin E

Protects cell membranes from oxidation

Vitamin C

Radical scavenger and regenerates vitamin E

Uric Acid

Scavenges hydroxyl radicals

Glutathione

Serves multiple roles in the cellular
antioxidant defense

Alpha Lipoic Acid

Effective as an antioxidant and in the
recycling of vitamin C

Carotenoids (including Beta Carotene)

Lipid soluble antioxidants located primarily
between lipid bilayers of cells

Bilirubin

May serve as an extra cellular antioxidant

Ubiquinones
Efficient antioxidants in its reduced form
The data in these tables was taken from Powers and Hamilton (1999)
compounds known as carotenoids, which are pigments synthesized within a number of plants.
Carotenoids are found in abundance in fruits and vegetables and dairy fats.
4

The term vitamin A is used to refer to the chemical name of retinol. In the small intestine,
beta-carotene is converted to retinal, which is subsequently converted to retinol. This conversion
and subsequent absorption takes place in the mucosal cell (Groff et al, 1995) and is dependent
upon the vitamin A status of the individual and vitamin A content of any given meal (Blomstrand
and Werner, 1967). Carotenoids and retinols released from consumed foods are packaged into
micelles and subsequently cross the brush border of the small intestine to enter the mucosal cells.
Within the mucosal cells, retinol is converted to retinyl esters and incorporated into the
chylomicrons for transport via the lymphatic system, to the liver. Beta-carotene can be converted
to retinal, which is converted to retinol and subsequently converted to retinyl esters to follow the
same fate as absorbed retinol. However, some beta-carotene is not converted to retinal and is
incorporated into the chylomicrons and distributed throughout the lipids of body tissues, mainly
adipose tissue and the adrenal glands (Guthrie and Picciano, 1995).
Beta-carotene is located in between the lipid bilayers of tissue cells. It lies parallel with
the membrane surface deep within the hydrophobic core of the two layers (van de Ven et al,
1984). It is a lipid soluble antioxidant that aids in the reduction of lipid peroxidation within cells
(Powers and Lennon, 1999). Beta-carotene has the ability to quench some free radical reactions
within membrane systems. This process entails the inactivation of electronically excited
molecules such as singlet oxygen (O2), generated from lipid peroxidation of cell membranes. In
singlet oxygen, the peripheral electron is excited to an orbital above that which it usually
occupies. Singlet oxygen can damage cells unless removed by antioxidants. Beta-carotene can
also react with peroxyl radicals that are involved in the oxidation of lipids, (Mascio, Murphy, and
Sies, 1991) thus contributing to the defense of tissue cells. This ability to quench free radicals
and other ROS can be attributed to the conjugated double bonds within the chemical structure of
5

carotenoids. Beta-carotene reacts with singlet oxygen by transferring excitation energy from the
oxygen so that it may return to its ground state, without any chemical change to the betacarotene.
Recommended Dietary Allowances and Toxicity
The Food and Nutrition Board of the National Academy of Sciences sets the
recommended dietary allowances (RDA) for selected vitamins and minerals. The RDA for
vitamin A is currently 2300 (women) - 3000 (men) IU. On most commercial labels, vitamin A is
measured in international units (IU). One IU is equal to 0.3 ug retinol and 3.6 ug beta-carotene,
or 0.3 retinol activity equivalents (RAE). Currently there is no RDA for beta-carotene or any of
the other vitamin A precursors. It is not uncommon to see levels as high as 25,000 IU of vitamin
A in the form of beta-carotene, in commercial vitamin supplements or mixtures. Intakes as high
as 180 mg (Groff et al, 1995) appear to pose no harmful side effects. This is due in part by the
body’s selective absorption of beta-carotene as discussed earlier. As consumption of betacarotene increases, the percentage of absorption decreases. A condition known as
carotenodermia may occur. This causes a yellowing of the skin, especially on the soles of the feet
and palms of the hands. However, this condition is harmless, and disappears following removal
of the carotenoids from the diet.
Beta-Carotene Supplementation and Exercise
Most research concerning antioxidants with exercise, have investigated how these
compounds may improve human performance. However, to date there is very little research
examining the effects of beta-carotene on muscular fatigue or endurance.
One study has shown differences, following supplementation with beta- carotene.
LeBlanc (1998) conducted a study in which trained runners ran a 5K race at maximum effort.
6

The subjects were assigned to two groups. One group received a placebo, and the other 15 mg of
beta-carotene per day for a period of one month. At the end of this period, 5K race time was
examined again. Afterward, subjects underwent a washout period of 2 months. Following this
washout period the groups were crossed over, and the group that had received the placebo
received the beta-carotene and vice versa, for one month. Following beta-carotene
supplementation, five kilometer race times showed an improvement from 19.91 minutes (while
taking the placebo), to 19.36 minutes. This improvement was found to be statistically significant
with a p value of 0.004. There was no clear cause for the increase in exercise performance, and
the study concludes that there was not a clear understanding of the mechanism for this
improvement. However, what is seen in this particular experiment may be a result of an
increased ability to resist fatigue rather than an improvement in muscular performance per se. In
endurance races a decrease in race time may be the result of a decreased rate of fatigue, rather
than an increase in speed or strength.
Function and Role of Vitamin E
There are eight compounds produced by plants that could be classified as vitamin E.
These compounds fall into two classes: 1) the tocols; 2) and the tocotrienols. The most
biologically active are the four tocols or tocopherols. They are alpha-, beta-, gamma-, and deltatocopherol. The most biologically active of those four is alpha tocopherol (Farrel and Roberts,
1994). Vitamin E content in food or tissue is measured in terms of tocopherol equivalents (TEs).
One TE corresponds to 1 mg of alpha-tocopherol, and is equal to one IU of alpha tocopherol.
Vitamin E is distributed in a wide range of foods. Vegetable oils, green leafy plants, and
the bran and germ of some plants represent the majority of dietary vitamin E sources. Vegetable
oils have the highest content of vitamin E per gram. However, the average serving of these in the
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diet is relatively small. The next highest food sources are fortified cereals followed by vegetables
(Guthrie and Picciano, 1995).
Absorption of vitamin E occurs in the jejunum via passive diffusion (Erdman et al, 1988;
Sokol, 1988). The vitamin is carried via micelles into the enterocytes. Similar to other fat soluble
vitamins, absorption of vitamin E improves when lipids are present in the diet (Bender, 1992).
Similar to beta-carotene, as vitamin E intake increases absorption decreases. Absorption rate can
vary between 20 to 50% (Groff et al, 1995) but, in special conditions may rise as high as 80%.
The supplemental use of vitamin E in doses as high as 200 mg, may result in a drop in absorption
to 10% (Farrel and Roberts, 1994).
Once vitamin E enters the enterocyte, it is incorporated into chylomicrons and
transported via the lymph. While in the lymph, vitamin E equilibrates with plasma lipoproteins,
(high density lipoproteins [HDLs], low density lipoproteins [LDLs]) and with erythrocytes (red
blood cells). In the erythrocytes, vitamin E is incorporated into the cell membrane.
Vitamin E (tocopherol) is distributed throughout the body primarily by the LDLs (Groff
et al, 1995). Uptake of vitamin E by tissue cells happens mainly in two ways: 1) uptake of LDLs
by LDL receptors (Traber and Kayden, 1984; Sokol, 1988); 2) or lipoprotein lipase hydrolysis of
the chylomicrons and very low density lipoproteins (VLDLs) (Groff et al, 1995). Once inside the
cell it binds to tocopherol binding proteins for transport to cell, mitochondrial, and microsomal
membranes (Farrel and Roberts, 1994). Vitamin E is distributed throughout the body tissues.
Most is stored in the adipose tissue with smaller amounts in the liver, lungs, heart, muscles,
adrenal glands and the brain. The amount of vitamin E in the adipose tissue increases as intake
increases. However, levels in the other tissues stays constant or increase at a very slow rate.
When intake is low, withdrawal from the liver and plasma is fairly rapid but, occurs slowly from
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the adipose tissue (Diplock, 1984). Depletion of vitamin E from the muscle occurs at an
intermediate rate.
The main function of vitamin E in the human body is as an antioxidant. It is the body’s
first line of defense against cellular membrane lipid peroxidation. In tissue cells, vitamin E is
embedded within the lipid bilayers. There, it can assert its ability to stabilize cell membranes and
break the chain reactions caused by free radicals and other ROS (Powers and Hamilton, 1999).
The reduction of molecular oxygen in tissue cells can generate a superoxide radical (O2-) and
later hydrogen peroxide (H2O2). These can lead to the formation of lipid peroxyl radicals (LOO).
Lipid peroxyl radicals can remove a hydrogen atom from polyunsaturated fatty acids (PUFA). If
these PUFA are located within the membrane of tissue cells, it can cause a chain reaction
throughout the cell membrane. These chain reactions must be broken to keep minimal the
amount of damage to cell membranes. Vitamin E can break these chain reactions by reacting
with lipid peroxyl radicals, thus preventing their abstraction of hydrogen in PUFA (Groff et al,
1995). This is done by providing hydrogen for the reduction of the lipid peroxy radical.
Furthermore, clinical tests suggest that it (vitamin E) may actually reduce the susceptibility of
low-density lipoproteins to oxidation by free radicals (Jialal and Grundy, 1992). Once vitamin E
has broken this reaction it is oxidized to create an alpha tocopheroxyl radical and must be
regenerated. This regeneration is carried out by ascorbate (vitamin C) via a series of interactions
between NADPH, and reduced glutathione (Packer et al, 1979; Groff et al, 1995; Wefers and
Sies, 1988). This relationship is further illustrated in a study by Brown, Morrice, and Duthie
(1997). They studied the results of a vitamin E supplementation protocol upon oxidative stress in
smokers and non-smokers. Smokers because of their habit, are in a perpetual state of oxidative
stress. Smoking brings into the body a higher than normal amount of ROS with which the
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antioxidant defenses must deal. In this study, fifty smokers had habitually lower plasma
ascorbate concentrations (p<0.02) and higher susceptibility to hydrogen peroxide (H2O2)
stimulated erythrocyte peroxidation (p<0.001) than did nonsmokers. They found that after 20
weeks of supplementation with either 70, 140, 560, 1050 mg alpha tocopherol/day, there was a
significant decrease in erythrocyte susceptibility to oxidation (p<0.001) in the group of smokers.
Moreover, there was a decline in plasma ascorbate concentration (p<0.02) in the nonsmokers
after prolonged alpha tocopherol supplementation. This may be an illustration of the relationship
between vitamin E and vitamin C discussed previously.
Recommended Dietary Allowances and Toxicity
The daily requirement for vitamin E increases as the intake of PUFA increases. On the
other hand, most foods high in PUFA are also high in vitamin E (Lehman et al, 1986). The RDA
for women and men is, 8 mg TE/day and 10 mg TE/day respectively. The normal intake of
vitamin E in American diets ranges from 4 to 22 mg TE/day in adults, who are not
supplementing their diet with exogenous vitamin E (Di Mascio et al, 1991). Depending upon the
intake of PUFA in the diet the actual need for vitamin E can range from 5 to 20 mg TE/day
(Guthrie and Picciano, 1995). The RDA for vitamin E is high enough to maintain a blood level
of around 0.5 mg/dl, which is considered safe. Deficiency in humans is extremely rare (Groff et
al, 1995). Usually individuals exhibiting deficiency in vitamin E are low birth weight infants,
individuals with malabsorption syndromes, and those suffering from abetalipoproteinemia.
Abetalipoproteinemia is a genetic disease in which apolipoprotein B, necessary for the formation
of chylomicrons, LDLs, and VLDLs, is lacking (Sokol, 1988). In addition, any disorder that
affects the absorption of fat will have an affect on the absorption of vitamin E. In the rare
instance of vitamin E deficiency, anemia can occur because of the hemolysis of red blood cells,
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as well as retinopathy, muscle weakness, and neurologic problems.
It appears that large doses of vitamin E may be consumed without harmful side effects.
Intakes between 400 and 800 mg TE/day have been taken for months or even years without any
harm (Council on Scientific Affairs, 1987). High dosages of vitamin E may interfere with the
functions of other fat soluble vitamins (vitamin K, beta-carotene) but, this is only seen in dosages
exceeding 1 g/day (Groff et al, 1995)
Vitamin E Supplementation and Exercise
A relationship between vitamin E and athletic training was first posed in the 1950s
(Cureton 1954). Cureton suggested that ingestion of wheat germ oil would enhance the rate of
improvement seen in physical performance following aerobic training in human subjects. At that
time, it was thought that vitamin E was the active agent within wheat germ oil. Since that time,
most research investigating vitamin E and exercise performance has involved animals and not
humans. In 1990 Novelli, Bracciotti, and Falsini (1990) saw a 50% increase in endurance time in
rats during exercise, following treatment with vitamin E. Swiss mice were injected
intraperitoneally with a solution of alpha tocopherol in olive oil (100mg / kg body weight), a
solution of three spin trappers (N-tert-butyl-alpha-phenyl nitrone [PBN], 5-5-dimethyl-1pirrolyn-N-oxide [DMPO], and alpha-4-pyridyl-1-oxide-N-tert-butyl-nitrone [POBN]) in saline
solution, or saline solution alone. Spin trappers are compounds that react with free radicals and
make them less reactive. Rats were exercised to exhaustion, four at a time, before and after
treatment by attaching 1 gram weights to their tails and allowing them to swim in a bath until
exhausted (exhaustion was defined as when a rat’s head submersed three times). Average time to
exhaustion for the alpha tocopherol treated mice went from 276 seconds to 415 seconds. Time to
exhaustion for the spin trapper treated mice also increased significantly: 1) PBN treated mice
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increased from 298 to 393 seconds; 2) POBN increased to 493 seconds; 3) DMPO increased to
555 seconds. The researchers believe the results of their study indicate that the trapping and / or
inactivation of free radicals may increase endurance during exercise.
In an interesting study by Sacheck, Decker, and Clarkson (2000) the connection between
vitamin E intake and moderate intensity exercise was examined. They recruited 24 female rowers
from a local college rowing team. After completing a 3-day food diary within one week of the
exercise test vitamin E intake was assessed. The rowers were assigned to two groups of 12
subjects. One group was a low fat intake group and the other was a high fat intake group. The
low-fat group was classified as those ingesting less than 40 grams of fat/day, and the high-fat
subjects ingested more than 60 grams of fat/day. None of the subjects were supplementing with
any nutritional substances, taking medications, using oral contraceptives, or consuming alcohol
during the study time period. Following diary assessment it was discovered that the low-fat
group was consuming 2.9 mg vitamin E/day and the high fat group 9.8 mg vitamin E/day. The
low fat group was consuming less than the normal intake range for vitamin E in American diets
(Di Mascio et al, 1991). However, they were also ingesting a very low fat diet which
consequently is low in PUFA. The ratio of vitamin E to PUFA (0.56 mg/g) was well above the
recommended ratio of 0.4 mg/g (National Research Council, 1989) for the low fat group. The
ratio for the high fat group was 0.69 mg/g. Subjects were instructed to run on a treadmill for 5
min at a 0% grade, thereafter they ran at a speed that elicited a rise to 75% of their age related
maximum heart rate (220-age), at a -10% grade (downhill) for 45 minutes. Venous blood was
collected immediately prior to exercise, immediately post exercise, and at 6, 24, and 48 hours
after exercise. Serum vitamin E levels were not significantly different between the two groups
pre- or post-exercise, nor were there any significant differences seen between low-fat and high12

fat groups in regards to creatine kinase, malondialdehyde (an indicator of lipid peroxidation), or
conjugated dienes (formed during the peroxidation of PUFA) pre- or post-exercise. There were
significant increases in plasma creatine kinase at 6, 24, and 48 hours post exercise in both
groups, when compared to pre-exercise values, but as previously expressed there were no
significant differences between the two groups (no significant interaction). They concluded that,
although the low fat group did not consume as much vitamin E as the high fat group, and they
were below the RDA for vitamin E, the intake of vitamin E was sufficient to help protect against
the oxidative damage brought about by the moderate-intensity exercise. Furthermore, since their
serum vitamin E levels were normal throughout the study, perhaps the body may be able to
compensate for low vitamin E intake in the low-fat subjects. It also may be possible that the ratio
of vitamin E to PUFA plays an important part as well. Although the intake of vitamin E was low,
the ratio was within the normal values. It is well established that the need for vitamin E increases
as PUFA intake rises. However, if these low fat individuals were consuming a lower than normal
amount of PUFA, then the amount of vitamin E they were ingesting may have been sufficient.
Another question that remains to be answered. Does the training status of these rowers have
more of an influence upon their ability to stave off the effects of oxidation during moderateintensity exercise than their vitamin E status? Being endurance athletes one would expect there
to be a larger than normal production of enzymatic antioxidants because of training (Roberson et
al, 1991). It remains to be seen how athletes or untrained individuals would respond to a bout of
high-intensity exercise, in respect to vitamin E status.
Although some animal studies may indicate that supplementation with vitamin E may
decrease exercise induced oxidative stress, in humans most research to date has not indicated any
improvement in endurance. Sumida, Tanaka, Kitao, and Nakadomo (1988) supplemented
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twenty-one healthy male college volunteers with 300 mg vitamin E for four weeks. The subjects
performed a pre- supplementation and post-supplementation protocol of exercising to exhaustion
using an incremental exercise test upon a Monark cycle-ergometer. The exercise test involved
subjects pedaling a Monark bicycle-ergometer at an initial work rate of 4 minutes at zero watts.
Thereafter, the work rate was increased by 15 watts every minute until a pedaling rate of 60 rpm
could no longer be maintained. Following data collection, the investigators found no significant
difference in VO2 peak (Control - 48.9 ml/kg/min; Vit E - 49.1 ml/kg/min) or time to exhaustion
(Control - 19.0 min; Vit E - 19.1 min). However, this was not a double-blind placebo controlled
trial. Lawrence et al (1975) supplemented groups of trained swimmers with 900 IU of alpha
tocopherol or placebo in a double-blind protocol for 6 months, but also found no difference
between the supplemented and placebo groups. Subjects were given 21 tablets of 300 IU of alpha
tocopherol or a placebo, every week. They were asked to perform an endurance swimming test
consisting of 10 laps of 100 yards with a 10 second rest in between. After one month of
supplementation, the two groups decreased their swimming time by an average of 3%. After six
months, those in the alpha tocopherol group had decreased their time by 6.8%, and the placebo
group had increased theirs by 6.2%. These differences however, were not found to be statistically
significant. This suggests the possibility that a crossover design, in which subjects are their own
control, might be helpful in detecting differences that may have been overlooked. Though there
is much research still to be done, it remains possible that vitamin E may need to be taken in
conjunction with other antioxidants (Balakrishnan and Anuradha, 1998; Powers and Hamilton,
1999; Schroder et al, 2000; LeBlanc 1998), to have an effect upon muscular endurance and / or
fatigue, and not just in the reduction of free radicals. It may be possible that these combinations
will have an effect upon the ability to sustain a given amount of work over time
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Researchers have used many different protocols and subjects to investigate the effect that
vitamin E would have upon muscular fatigue. Of the studies previously cited none used the
double blind-placebo controlled design that is most preferred. One injected each of three groups
with a compound (either spin trappers, alpha tocopherol, or saline solution) to examine their
effects (Novelli et al, 1990) however, this was not a double blind procedure. Nor was the study
by Sumida et al (1988), in which they investigated the differences in VO2 and exhaustion, a
double blind study. Lawrence et al (1975) did use the double blind design in their investigation.
However, they chose not to employ a crossover within their study. There have also been a
number of different dosages and methods for ingesting the supplement. Some researchers
injected subjects with alpha-tocopherol and some had subjects ingest it in tablet form. Thus,
there is no standard dosage that is used to determine the effect of vitamin E upon work or
fatigue. Interestingly, Sacheck et al (2000) chose to monitor vitamin E intake levels rather than
have subjects supplement with exogenous vitamin E. However, no differences were seen in those
ingesting a high fat or low fat diet. With that in mind, training status may result in a lack of any
effect of the two diets in that particular investigation. This may also have been the reason no
significant effect was seen with Lawrence et al (1975) as well.
Function and Role of Vitamin C
Vitamin C is probably the most supplemented and researched vitamin known to man. The
chemical name for vitamin C is ascorbic acid or ascorbate. At one point in history, it was known
as antiscorbutic because of its ability to prevent scurvy (Guthrie and Picciano, 1995). Human
beings are one of the few mammals that cannot synthesize ascorbic acid. So therefore, they must
obtain their supplies of this vitamin through food sources.
The best sources of ascorbic acid are found in foods of plant origin. Foods such as
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oranges, cantaloupe, broccoli, green peppers, grapefruit, lemons, and strawberries are among the
highest in vitamin C content. When any of these foods are cooked or processed using heat, they
can reduce the amount of vitamin C content. Most plants containing vitamin C are best
consumed raw to avoid any loss in the content of the vitamin.
Ascorbic acid has many functions within the human body. It is a water soluble vitamin
vital in carnitine synthesis (needed for the transport of fatty acids into the mitochondria),
collagen formation, neurotransmitter synthesis, and most importantly, as an antioxidant. It also
plays a part in the process to convert cholesterol to bile acids and aids iron absorption (Guthrie
and Picciano, 1995).
After ingestion, absorption of vitamin C occurs in the jejunum (Groff et al, 1995).
Absorption takes place primarily via active transport into the intestinal cells. Before being
absorbed, it is possible that some ascorbate will be oxidized to form dehydroascorbate because of
the presence of Fe+++ present in the intestine (Englard and Seifter, 1986; Guthrie and Picciano,
1995). Dehydroascorbate can be absorbed by passive diffusion into the cells. Once inside the cell
dehydroascorbate is reduced back to ascorbic acid by dehydroascorbate reductase. Ascorbate
moves across the basolateral membrane of the intestinal cells by sodium-independent carriermediated transport (Groff et al, 1995). After moving through the cells, ascorbate moves into the
blood stream and is carried by the plasma throughout the body. It moves with ease into body
cells. Some tissues have a greater concentration than others. The highest concentration is found
in the adrenal and pituitary gland (50 times the concentration in serum). More intermediate levels
are found in the liver, pancreas, lungs, and kidneys (5 to 30 times the concentration in serum).
Lower levels are found in the muscles, and red blood cells. When amounts up to 100 mg are
consumed, 80-90% of all vitamin C is absorbed (Guthrie and Picciano, 1995). However, as the
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amount of vitamin C ingested increases, absorption decreases. As little as 16% is absorbed when
amounts around 12 grams are consumed.
The amount of vitamin C within the entire body can be between 1.2 to 2.0 grams when
100 mg/day of the vitamin are ingested. This is the level deemed necessary to protect the body
from scurvy for 90 days (Guthrie and Picciano, 1995). If large amounts of vitamin C are
consumed the body will only absorb and retain enough to maintain a plasma concentration of 1.2
to 1.5 mg/100 ml. Anything beyond that needed to maintain these levels is excreted.
As an antioxidant, ascorbic acid may react with OH (hydroxyl radical), O2- (superoxide
radical), H2O2 (hydrogen peroxide), and HO2 (hydroperoxyl radical). Once ascorbate reacts with
these ROS, semidehydroascorbate radical (also called ascorbyl) and water, are formed. Two
ascorbyls react to form ascorbate and dehydroascorbate (Groff et al, 1995). Dehydroascorbate
can react with glutathione to form ascorbate. As a reductant, vitamin C can reduce cupric (Cu2+)
to cuprous (Cu+) ions, and ferric (Fe3+) to ferrous (Fe2+) ions (which aids in their absorption in
the small intestine). These two products (Cu+, Fe2+) may react with free radicals and other ROS,
and may cause damage to cells via the generation of more ROS (Groff et al, 1995). Ascorbate
can react in aqueous environments within the body, including blood, extracellular fluid, and cell
interiors, before any oxidative damage may occur to lipids (Frei, 1991).
Recommended Dietary Allowance and Toxicity
The RDA for vitamin C is currently set at 60 mg/day for adult men and women. This is
the amount deemed necessary to ensure that body tissues are saturated with the vitamin (a body
pool of 1500 mg). Some nutritionists believe that the RDA should not be greater than the amount
needed to prevent scurvy (10 to 12 mg/day) (Guthrie and Picciano, 1995). Conversely, there is
some evidence that saturation of the tissues of young men with ascorbic acid may require an
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intake of 138 mg/day (Jacob et al, 1987).
Vitamin C is relatively non toxic (Alhadeff et al, 1984). However, toxicity is more likely
when large doses (in excess of 1 gram) are ingested several times a day. This is because
absorption of vitamin C in the small intestine is saturable and dose dependent (Groff et al, 1995).
This results in a more pronounced absorption of vitamin C throughout the day as opposed to
taking one large dose. However, any vitamin C in excess of a body pool between 1200 and 2000
mg is filtered by the kidneys and excreted in the urine. Finally, unabsorbed vitamin C in the
intestine can cause diarrhea because of its osmotic effect (Alhadeff et al, 1984), which draws
water into the intestinal tract.
Vitamin C Supplementation and Exercise
For years, athletes have been supplementing with vitamin C with the belief that it will aid
or at least help to maintain athletic performance. However, much of the research aimed at
investigating this long held belief has been inconclusive. In one particular animal study, Lang,
Gohil, and Packer (1986) supplemented guinea pigs with up to 4 grams/ kg of body weight of
vitamin C for two weeks and observed an increase in endurance capacity. At the same time, they
did not see a concomitant increase in vitamin C tissue levels, but saw a decrease in muscle
vitamin E levels. In addition, ubiquinone levels stayed constant. They suggested that this might
show a tissue specific interaction between C, E, and ubiquinone. Human studies reveal
conflicting results. As early as 1966, Spioch, Kobza, and Mazur (1966) injected volunteers with
500 mg of vitamin C before a 5-minute step test to evaluate the effectiveness of supplementation
on human performance. They found a reduction in oxygen consumption (by 12%), oxygen debt
(by 40%), and pulse rate (by 11%). Unfortunately, this study was uncontrolled. Consequently
there was no way to know if the improvements were attributed to the supplementation or training
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effect. In 1985 a vitamin C supplemented group of 16 healthy female Indian physical education
college students, saw improvement in physical efficiency (by 5.0 on the Harvard Step Test), and
a 9-minute walk / run (236.77 meters) (Samanta and Biswas, 1985). However, only the
improvement in 9-minute walk in the supplemented group was significant at p<0.05. Students
were randomly assigned to an experimental group and a control group. Each subject in the
experimental group was given a 500mg vitamin C tablet every day for four weeks.
Unfortunately, they did not compare results against a sedentary group to see differences between
physically active individuals and the latter. In a study using 286 American Air Force officers,
half of whom supplemented with 1 gram of vitamin C daily for 12 weeks, a small improvement
was seen in endurance performance (12-minute run) between supplemented and unsupplemented
subjects (Gey, Cooper, Bottenberg, 1970). However, this improvement was not statistically
significant (less than 1%). Keren and Epstein (1980) saw no improvement in maximum oxygen
uptake during a cycle-ergometer test, in untrained subjects after they ingested 1 gram of vitamin
C daily. The untrained subjects were assigned to a supplemented group or a placebo group. Each
group was given either 1000mg per day of vitamin C or a placebo for 21 days in a double-blind
manner. Before and after supplementation VO2 max and anaerobic capacity were measured.
After 21 days of aerobic training (running and hiking), in conjunction with the supplementation
protocol, no differences were seen (p<0.05) in the aerobic or anaerobic capacities of the two
groups.
In 1990, a group attempted to see if a vitamin C restricted diet would have an impact
upon physical performance in a group of healthy volunteers (van der Beek et al, 1990). Twelve
healthy subjects were prescribed diets providing low vitamin C intake (20% of the Dutch RDA)
for seven weeks. In a double blind manner, six of the subjects were assigned to an experimental
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group and the other six were assigned to the control group. Both groups also received twice the
RDA for all other vitamins during the study to ensure no deficiency other than vitamin C. There
was a 3-week introductory period preceding the 7-week experimental period. The first 2 weeks
of the introductory period subjects consumed their regular diet and vitamin C equal to the Dutch
RDA (DRDA) (50 mg/day). At the last week of the introductory period subjects began
consuming the experimental diet. Once the 7-week experimental period began, the control group
consumed the prescribed vitamin C deficient diet with twice the DRDA of all vitamins other than
vitamin K, for the entire supplementation period. The experimental group continued on the diet
but at weeks 1-3 they also supplemented with twice the DRDA for all vitamins other than C and
K. At weeks 4-7 they ingested an additional 15 mg vitamin C per day (for a total of 25 mg/day).
Following this 7-week vitamin C deficient regimen the experimental group received a dose of
vitamin C per day that was twice as high as the DRDA. Blood was drawn at the before the
experiment and at weeks 3, 7, and 10. Measures of VO2max and onset of blood lactate (OBLA)
were measured at the times that blood was drawn. VO2max was determined via an incremental
cycle-ergometer test. Subjects pedaled at 50 watts at a rate of 60-80 rpm. After 2 minutes workrate was increased 50 watts and subsequently 25 watts every 2 minutes thereafter to exhaustion.
Blood was drawn during the last 30 seconds of each step to determine blood lactate. Following
data analysis it was found that there were no significant differences between the experimental
group and the control group for aerobic power or OBLA. There were significant differences
between the experimental group and the control group with respect to serum vitamin C levels
(p<0.01). There was a slight increase in heart rate at each of the three exercise tests in the
experimental group, but this increase was not significant. However, the authors hypothesized that
this increase may have been related to the lower than normal serum vitamin C level and the
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effect upon carnitine synthesis and / or catecholamine receptor sensitivity. But no evidence of
this has been confirmed. Being that subjects were never totally restricted from ingesting vitamin
C during the course of the study, it may be difficult to ascertain its true effect upon aerobic
power and OBLA. In this study subjects were supplemented with the DRDA for vitamin C prior
to the initial restriction period and then for the first three weeks were restricted to 20% of the
DRDA and then the next four weeks to 50% of the DRDA. Perhaps, for that short period, the
body was able to maintain a level of serum vitamin C high enough to maintain aerobic capacity,
by releasing some vitamin C from other tissues throughout the body (i.e. adrenal gland, pituitary
gland, liver, etc.).
As with vitamin E, many diverse protocols have been used to test the effectiveness of
vitamin C on work capacity. Some, like Lang et al (1986), have used animals and, some have
used human subjects. There have been varying results between species among the studies cited,
and there does not appear to be a clear-cut answer as to how effective vitamin C may be. Some
have used trained volunteers (Samanta and Biswas, 1985; Gey et al, 1970;), while others have
used untrained subjects (Spioch et al, 1966; Keren and Epstein, 1980; van der Beek et al, 1990).
There has also been a wide variety of experimental designs. Some used no controls, while others
used a control group. At least two used a double-blind method (Keren and Epstein, 1980; van der
Beek, 1990) while most did not. In human subjects, the dosages range between 500mg and
1000mg per day. Most studies examined the chronic effect of vitamin C supplementation upon
muscular work and / or aerobic capacity, while only one examined the effect of an acute dosage
of the vitamin. In addition, one study examined the effect of chronic versus acute dosing upon
human subjects. Allesio et al (1997) supplemented subjects with 1000 milligrams of vitamin C or
a placebo, per day for 1 day and 2 weeks. At 1 day and at 2 weeks subjects performed 30 minutes
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of submaximal exercise. Before and immediately following exercise plasma thiobarbituric acid
and reacting substances (TBARS) and, oxygen radical absorbance capacity (ORAC) were
measured. TBARS are biomarkers of oxidative damage (LeBlanc, 1998) used to indirectly
measure the extent of lipid peroxidation in biological systems. They (Alessio et al, 1997) found
that following the exercise TBARS were 12.6 and 33% above resting values in the supplemented
group, compared to 46% higher in the placebo group. No changes were seen in ORAC. When
comparing oxidative stress (represented by the ratio of TBARS to ORAC), the placebo group
noticed a 32% increase compared to 5.8 and 25.8% in the vitamin C group at 1 day and 2 weeks,
respectively. This led to the conclusion that oxidative stress was higher in those who ingested the
placebo, than those who ingested vitamin C.
None of the aforementioned investigations were conducted in a double-blind crossover
design. This design would be the most thorough method of detecting any differences between or
within an experimental group and, it would be the method of choice for a subsequent study on
this subject.
Antioxidant Combinations
There have been a few groups who have attempted to study the effects of some
antioxidants in combination and how they may effect muscular work or endurance. Rokitzki et al
(1994) set out to examine if supplementation with antioxidants could influence lipid peroxidation
and muscle enzymes. The subjects were 22 trained long distance runners. Half of the subjects
ingested an antioxidant capsule of 400 IU alpha tocopherol and 200 mg vitamin C per day, while
the others received a placebo for a total of 4.5 weeks. At the end of the supplementation period
the subjects participated in a marathon race. Serum measures of retinol, ascorbic acid, betacarotene, alpha tocopherol, malondialdehyde, uric acid, glutathione peroxidase, and catalase
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were taken at 4.5 weeks before, immediately before and after, and 24 hours after the marathon.
Serum concentrations of alpha tocopherol and ascorbic acid increased significantly after the 4.5
week supplementation period in the supplemented group. There were no significant changes in
glutathione peroxidase or catalase. There was a significant increase in creatine kinase
concentration immediately after and 24 hours after the marathon, in both the supplement group
and control group. However, the creatine kinase increase in the supplemented group was
significantly lower than in the control group. As creatine kinase is an indicator of muscle damage
it was concluded that the supplementation with the alpha tocopherol / vitamin C combination
helped to reduce the amount of blood creatine kinase increase during exercise. However, one
drawback is that there was no way of measuring the intensity at which the subjects ran the race.
It may be possible that they were running at a much lower pace than usual, which would not
necessarily be comparative to results after running as fast as they could cover the distance.
Similar results were found by another group recently (Bryant, Ryder, Martino, Kim, and Craig,
2003). They used seven trained cyclists in which each ingested two capsules per day containing
these four treatments: placebo (placebo plus placebo); vitamin E (400 IU per kg plus placebo);
vitamin C (1 gram plus placebo); and vitamin C and E (1 gram of C and 200 IU per kg vitamin
E). The treatment order was placebo, vitamin C, vitamin C and E, vitamin E. Each subject
ingested the treatment in the same order. Each supplementation phase lasted for 3 weeks for a
total of 12 weeks. At the end of each phase subjects performed a steady state ride on a cycle
ergometer for one hour followed by a 30-minute performance ride. The steady state ride was at
70% of VO2 max at a pedal rate of 90 rpm. Immediately afterwards, the performance ride was at
the same workload, but subjects could establish their own pedal rate. Blood samples were
collected immediately before and after the exercise trials and analyzed for malondialdehyde and
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lactic acid. Results showed that malondialdehyde levels pre-exercise (2.94 umol and 4.81 umol)
as well as post exercise (4.32 umol and 7.89 umol), were lower during the vitamin E phase than
during the placebo phase. Lactic acid levels were also lower in the vitamin E supplementation
period than the other three periods, although not statistically significant. They also noted that
total work levels decreased after each supplementation phase. Although interesting it would
appear that because these subjects were training during the study, their training may be having
more of an effect upon these measures than the actual supplementation regimen. Additionally,
each supplement was only taken for 3 weeks which may not be enough time to evaluate each
individually especially considering that the third phase was a combination between C and E. A
larger study utilizing a crossover design, untrained subjects, and perhaps a washout period would
give a clearer picture to the effect of either of these antioxidants. However, the authors point out
that because of time restraints they were unable to perform a washout in this particular study.
Another group set out to investigate the influence of a vitamin C and E combination upon
muscular damage using trained athletes similar to an aforementioned study. Dawson et al, (2002)
had 15 male distance runners divided into two groups. One group supplemented with 500 mg of
vitamin C and 500 IU of vitamin E, or 1000 mg vitamin C and 1000 IU vitamin E, for 4 weeks.
The other group received a placebo. Following this first supplementation period subjects ran a 21
km race as fast as possible. Afterwards, there was a 4-week washout period followed by a
crossover in the supplementation regimen for each subject. Following another 4-week
supplementation period another 21 km race was run. Venous blood was taken before,
immediately after, and 24 hours after each run. Samples were analyzed for creatine kinase,
myoglobin, malondialdehyde, and both vitamins. There was also a subgroup that had muscle
biopsies taken 24 hours before and 24 hours after each run. Both vitamin dosages produced very
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similar results so, vitamin groups were combined into one group. There were significant within
group differences (p<0.05) seen in serum creatine kinase, and myoglobin levels, but not
malondialdehyde, after the run. However there were no between group differences for those
same measures. In the biopsy samples there were changes seen consistent with endurance
training but, again no significant differences between the placebo and supplemented conditions.
They concluded that this dosage of vitamin C and E did not reduce biochemical or muscle
structural indices for damage in these runners. It appears that it may be possible that these
runners were so highly trained that they may already have more than enough enzymatic
protection through adaptation, against the affects of oxidative stress in working muscles. A 21
km run is an extremely long event and there is no indication of the workload that these
individuals were using in the study. The authors assumed that the athletes were running as fast as
possible, but there was no way to measure this. In a long event as this it is quite possible that
these runners never reached a point at which their already enhanced enzymatic antioxidant
systems was over stressed. If the authors had required the subjects to run on a treadmill, true
workload may have been quantified and compared rather than relying on the subjects honest
effort.
Pro-oxidant Activity of Beta Carotene, Vitamin E, and Vitamin C
Beta-carotene, vitamin E, and vitamin C are antioxidants. However, it has been suggested
that they may also serve as pro-oxidants in certain situations. They may promote oxidation via
their action upon certain molecules, such as cupric (Cu2+) and ferric (Fe3+) ions, or depending
upon which nutrient, by the failure to regenerate after serving in their role as an antioxidant.
There have been some reports of pro-oxidant effects of beta-carotene in vitro when high
doses have been administered. However, the in vitro pro-oxidant effect of beta-carotene was
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dose dependent only in an environment of 100% oxygen pressure(Palozza et al, 1995). Palozza et
al, (1995) used rat liver microsomal membranes exposed to 2,2` -azobis (2-amidinopropane)
(AAPH), a radical initiator, to illustrate this point. They showed that at a PO2 of 150 mm Hg
beta-carotene acted as an antioxidant, inhibiting AAPH induced malondialdehyde (MDA)
formation. However, at 760 mm Hg PO2 beta-carotene lost its antioxidant properties resulting in
an increase in lipid peroxidation. Their group used four different concentrations of beta-carotene
to illustrate the point that different dosages would elicit a slightly different effect. At a PO2 of
150 mm Hg, there was a decrease in MDA at each of four successively higher concentrations of
beta-carotene. On the other hand, at a PO2 of 760 an opposite effect was seen. At the same four
successive concentrations of beta-carotene an increase in MDA is seen. Later they showed that
the effect was prevented by a concomitant addition of alpha tocopherol, illustrating the
cooperative interaction of these two antioxidants. Another study showed that beta-carotene acted
as an antioxidant and inhibited AAPH induced lipid peroxidation in normal and in tumor cells at
150 mm Hg PO2 (Palozza, P. et al, 1997). However, when PO2 was increased to 760 mm Hg
beta-carotene exhibited a pro-oxidant effect, in addition to losing its antioxidant effectiveness. It
was noted that the pro-oxidant activity was more pronounced in the tumor cells than in the
normal cells. More study is needed to investigate these effects in vivo. It is possible that betacarotene is incorporated into biological membranes in vitro differently than in vivo (Liebler,
D.C. et al, 1997). PO2 in living tissues is much lower than those in the aforementioned studies.
Arterial blood PO2 is 100 mm Hg and in most tissues it is 40 mm Hg or less (Vander et al, 1990).
Therefore, it is likely that any pro-oxidant properties displayed by beta-carotene in vivo would
not be caused by a high partial pressure of oxygen.
The pro-oxidant effect of beta-carotene may be caused by the auto-oxidation of beta26

carotene at higher PO2 values in vitro. It may be possible that at high oxygen PO2, a chaincarrying beta-carotene peroxyl radical is formed (Burton, 1989; Burton and Ingold, 1984;
Kennedy and Liebler, 1991). This may be the reason why antioxidant effectiveness is reduced in
high PO2 environments (Kennedy and Liebler, 1992). Carotenoids may interact with free radicals
in three ways: 1) electron transfer; 2) hydrogen abstraction; 3) and radical species addition
(Young and Gordon, 2001). The products of these reactions may react with oxygen to produce
peroxyl radicals. In the end, it may not be a pro-oxidant effect that is seen, but a reduced
antioxidant effect (Palozza et al, 1995). An environment of 100% oxygen is not physiologically
tangible so, it is not likely that beta-carotene would display a pro-oxidant effect in vivo (Burton
and Ingold, 1984). However, as there are varying PO2 throughout body tissues, all less than 40
mm Hg, it is possible that beta-carotene may be more or less effective as an antioxidant
depending upon the tissue.
Few reports show any pro-oxidant effects of vitamin E. Most, if not all, have been in
vitro studies, and most have been in abnormal physiological environments. As discussed
previously, alpha tocopherol is a major antioxidant present in LDLs (Sokol, 1988). It is assumed
that increasing the amount of alpha tocopherol in LDLs would make them less susceptible to
oxidation. However, under mild oxidative conditions it has been shown that increasing
tocopherol within the LDL may increase LDL susceptibility to oxidation (Bowry et al, 1992).
The reason for this increase in oxidizability is the action of the alpha tocopheroxyl radical. This
radical, sustained within the LDL for a sufficient amount of time, will begin to oxidize the
PUFAs within LDL in vitro (Bowry and Stocker, 1993). Since alpha tocopherol scavenges free
radicals and other ROS, the more alpha tocopherol present, the increased amount of radicals that
can or will be scavenged (Witting et al, 1999). During high fluxes of ROS, vitamin E prevents
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lipid oxidation. However, when there is a low level of ROS, lipid peroxidation may be caused by
vitamin E, specifically alpha tocopheroxyl radical. Normally, alpha tocopheroxyl radical can also
participate in the reduction of lipid peroxyl radical into non radical products (Witting et al,
1999). When lipid peroxyl radical levels are not high, alpha tocopheroxyl radical will begin to
oxidize PUFAs if there are insufficient co-antioxidants, such as vitamin C, to regenerate alpha
tocopherol (Bowry et al, 1995). In an experiment by Kontush et al (1996) they showed that, in
vitro, this pro-oxidant effect is apparent under certain circumstances. In human plasma and LDLs
alpha-tocopherol developed antioxidant and pro-oxidant activity depending upon oxidative
conditions and presence of vitamin C. In what was termed a “strong oxidative condition”
(plasma diluted 150 fold or two fold, with 50 micromoles CU2+ and 25 millimoles of AAPH,
respectively) alpha-tocopherol displayed antioxidant behavior in both plasma and LDLs
regardless of the amount of vitamin C in the sample. Under “mild oxidative condition” (plasma
diluted 150 fold with 0.5 micromoles and 333 micromoles of AAPH respectively) alphatocopherol was shown to have a pro-oxidant effect. However, it was noted that this was only
seen when the samples were “virtually free” of vitamin C or the amount was much lower than
physiological levels (Kontush et al, 1996). Once vitamin C was added to these samples
antioxidant activity of alpha-tocopherol was restored. In the final analysis it was pointed out that
alpha-tocopherol should always function as an antioxidant, as long as the concentration of other
co-antioxidants, such as vitamin C is high enough to regenerate alpha-tocopheroxyl radical back
to alpha tocopherol. Considering vitamin C’s high concentration in human plasma it is highly
probable, in vivo, vitamin E should act as an antioxidant regardless of the oxidative conditions
(Kontush et al, 1996). We know that, in vivo, vitamin E indeed usually acts as an antioxidant
(Groff et al, 1995; Janero, 1991). It appears that only in situations where co-antioxidants, such as
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vitamin C, are exhausted or, there is an abnormal condition like thalassemia (Olivieri et al, 1994)
or Wilson’s disease (Ogihara et al, 1995) is there a chance of pro-oxidant activity by vitamin E in
vivo.
There are very few studies showing any pro-oxidant effects of vitamin C. Generally, the
pro-oxidant effect of vitamin C is not seen via its direct action upon other molecules, rather, it is
with its action upon Cu2+ and / or Fe3+ (Herbert, 1996). As previously stated, after ascorbic acid
reduction the products, Cu+ and Fe2+, can react with hydrogen peroxide or oxygen to form
hydroxy radicals or superoxide radicals (Groff et al, 1995). Afterwards these ROS can damage
membranes by attacking lipids and proteins embedded in the membrane itself. Most reports of
ascorbic acid and a possible pro-oxidant effect were seen in studies investigating tumor growth
and cancer (Alcain et al, 1990). In certain populations in which there is the potential for the
accumulation of iron, such as hemochromatosis or thalassemia, ascorbic acid supplementation
may cause an accumulation of toxic levels of iron (Schwartz, 1996). In addition, high levels of
iron provide a large supply of substrate for hydroxyl ion formation, which ultimately can lead to
lipid peroxidation (Wagner et al, 1993).
Muscular Fatigue
Muscular fatigue has been defined as “the failure of a muscle fiber to maintain tension as
a result of previous contractile activity” (Vander et al, 1990). High muscular forces can be
maintained for a shorter period than low muscular forces (Lieber 1992), and a direct result of
muscular fatigue is a decline in the rate of force production. It has been shown that substrate
depletion can be a major factor in the fatigue of contracting muscle, depending upon the intensity
of the exercise being performed. In low force, endurance type activities, fatigue may depend on
the amount of glycogen available. In high force, shorter time interval activities, fatigue may be
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dependent upon the muscles ability to replenish ATP via ATP-PC system, anaerobic glycolysis,
and / or oxidative phosphorylation. If muscle ATP demands are not adequately met, then force
production attenuates over time (Lieber 1992). Also, fatigue in shorter time, high force activity
is caused in part by the increase in intracellular acidity brought about by lactic acid buildup
(Vander et al, 1990).
In addition to substrate availability, there are numerous other theories for the mechanisms
involved in fatigue. Among those are disturbances in electrolyte balance and / or changes in
skeletal muscle oxygen-reduction status (Powers and Lennon 1999). In the study by Novelli et al
(1990), spin trappers were used to scavenge free radicals in exercising rats. Spin trappers are
compounds reacting with free radicals, and may even be classified as a free radical scavenger.
The rats were exercised to exhaustion, and compared to rats that had undergone the same
protocol, but without receiving the spin trappers. Those that had received the spin trappers had a
longer time to exhaustion (on average 185.7 seconds longer). Reid, Haack, et al (1992)
determined that: 1) muscular contraction increases intracellular oxidant levels; and 2) reactive
oxygen intermediates promote low frequency (fibers stimulated at 30 Hz as opposed to 200 Hz,
for five minutes) fatigue. Their study involved rat diaphragm bundles mounted in chambers
containing Krebs-Ringer solution loaded with 2',7'-dichlorofluorescin (a fluorochrome that emits
at 520 nm when oxidized). Bundles were artificially stimulated to contract repetitively at 30 Hz.
Increase in ROS were shown during stimulation via the fluorochrome during the period of
repetitive contractions.
Measuring fatigue is a very complex notion, as it can be influenced by both physical and
psychological factors (Astrand and Rodahl, 1986). It is not uncommon to perceive a certain work
output as being strenuous one day as opposed to the previous day. An example of the
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psychological influence of fatigue is in track and field. Many times we have seen an athlete
finish a race in victory, and take a victory lap, all while his competitors are sprawled on the
track. All of the athletes are fatigued but, for some reason the winner always seems to have the
energy to celebrate. This is most certainly due to some psychological factor. Factors that may
possibly play a part in muscular fatigue include central nervous system fatigue, peripheral nerve
fatigue, and neuromuscular junction fatigue. The control sequence for activation of voluntary
muscle as posed by Astrand (1986) occurs in this order; Mood - Brain - Spinal Cord - Peripheral
Nerve - Neuromuscular Junction - Muscle Fiber Membrane - Sarcoplasmic Reticulum - Ca2+
Ions - Actin and Myosin Interaction. Central nervous system fatigue is sometimes referred to as
psychological fatigue (Vander et al, 1990). This is illustrated by a failure of the cerebral cortex to
send signals to the motor neurons, which can lead to the failure of muscle fibers to contract, even
though the muscles are not fatigued. In the case of an athlete his performance may depend on his
“will to win” (or mood / motivation) to overcome this type of fatigue. However, Merton (1954)
showed that this may not necessarily be the case. In his classic study he had subjects performing
a number of repeated contractions and as time wore on he would superimpose a large electrical
stimulation over the voluntary contraction. He hypothesized that if CNS fatigue had any
influence upon muscular fatigue then the artificial stimulation would increase force produced
during a voluntary contraction. No force increase was observed in this study so he concluded that
CNS fatigue was not a factor in muscle fatigue. Bigland-Ritchie, Kakulka, Lippold, and Woods
(1982) showed that although force may decrease over time within a muscle, they demonstrated
that there is no change in muscle mass action potential and would suggest that the neuromuscular
junction is not the weak link in muscular fatigue. Gandevia, Herbert, and Leeper (1998) also
showed that although there may be development of muscular fatigue as muscular work is
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occurring, the capacity to maintain maximal levels of activation can be maintained.
Measuring fatigue in a non-invasive fashion has become a lot easier today with the help
of computerized dynamometers. Researchers have used a number of different protocols to
measure fatigue, however most have been based upon the premise that as a muscle(s) fatigues,
force attenuates. The most common measurements used are peak torque, work, and power. For
example, Svantesson et al (1998) studied fatigue during repeated eccentric and concentric
contractions of the plantar flexors. Subjects were tested to see if there was a difference in fatigue
development during concentric actions versus concentric-eccentric actions. A protocol for
measurement of the concentric was performed and compared against a similar protocol for
measurement of the eccentric, using plantar flexion as the action tested on the isokinetic
dynamometer. The test was performed to exhaustion, and the total amount of work was recorded
at the end of each test. They found that work declined similarly over time in both tests and, that
when evaluating fatigue during muscular performance, the concentric-eccentric test should be
used.
In a study by Pincivero, Gear, Moyna, and Robertson (1999), the effects of rest interval
on quadriceps torque were tested. The study used two groups of subjects who were each assigned
a different protocol to perform on a Biodex System II Isokinetic Dynamometer. All the subjects
performed four sets of twenty maximal isokinetic knee extensions at an angular velocity of 180
degrees per second. Group one was given a 40 second rest between each set and, group two was
given a 160 second rest between sets. The results showed that there was a significantly greater
decline in peak torque (p<0.05), total work (p<0.05), and average power (p<0.05) with group one
when compared to group two.
In a unique study by Ellenbecker and Roetert (1999), they attempted to show if there was
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a difference in the fatigue rate between shoulder external and internal rotation of the dominant
and non dominant arms, in elite junior tennis players. The protocol consisted of the subjects
undergoing bilateral isokinetic testing with 90 degrees of glenohumeral joint abduction. They did
twenty maximal effort concentric contractions of the external and internal rotation, at a speed of
300 degrees per second. The fatigue was measured by calculating a fatigue ratio. The fatigue
ratio was calculated by dividing the work in the last 10 repetitions by the work in the first 10
repetitions. They found significant difference between the fatigue ratios for the external versus
the internal rotations but, no difference between the dominant and non dominant arms.
Therefore, it would seem that work is a viable measurement of fatigue rate of muscles while
investigating the effect of supplementation on fatigue.
Summary
As mentioned previously, athletes and fit individuals are constantly under a barrage of
advertising from vitamin and supplement manufacturers promoting the use of vitamin
supplements. Many young athletes spend upwards of hundreds of dollars on these supplements
every month. However, it has been shown that most athletes consume more than enough of the
RDA for most nutrients (ADA, 2000) in their normal diets - which contains more calories on
average than the average person. If this is the case, and the manufacturers know this, then the
constant advice to ingest vitamin supplements is not based upon science but, rather the ignorance
of the target audience.
As it has been shown, there are any number of protocols and dosages that have been
employed in investigating the effectiveness of the antioxidants in question, both alone and in
combination. However, there is no consistency among the many methods and combinations
employed. It is accepted that vitamin E is the main chain breaking antioxidant with respect to the
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protection of the membranes of tissue cells. Although one study has shown an improvement in
time to exhaustion while supplementing with vitamin E in rats (Novelli et al, 1990), it has not
shown to be an effective substance to help reduce fatigue by itself (Sacheck et al, 2000; Sumida
et al, 1989; Lawrence et al, 1975). However, there are some diverse methods used in some
studies to test the effectiveness of vitamin E. One consistent characteristic in some of the
investigations is the use of endurance trained subjects (Sacheck et al, 2000; Lawrence et al,
1975). As mentioned previously, there is an accompanying increase in the enzymatic
antioxidants in endurance trained subjects (Miller, 1992). It may be possible that their training
status may supercede any effect of supplementing in these individuals in during submaximal
exercise. Sumida et al (1989) found no difference with vitamin E supplementation in cycle time
to exhaustion or VO2 max while using untrained healthy subjects for the investigation. However,
the study was neither double blind and involved no placebo group, consequently there is no
guarantee that the results are not biased.
As stated earlier, vitamin C is probably the most studied vitamin among the three
antioxidants mentioned. There have been all manner of protocols followed to investigate the
antioxidant properties of vitamin C and its influence upon muscular work. In the study by Lang
et al (1986) we see an improvement in endurance capacity in guinea pigs who have been
supplemented with 4 g/kg of vitamin C. In human subjects, nonetheless, there are mixed results.
Samanta and Biswas (1985) supplemented 16 healthy adult females with 500 mg vitamin C or
placebo for 4 weeks. They saw improvement in distance covered (1813.83 meters pre-test,
2026.75 meters post-test) during a nine minute walk / run in the vitamin C group after the 4
weeks when compared to before supplementation (p<0.05). The placebo group saw no
improvement. Gey et al (1970) supplemented 286 male air force officers with 1000 mg vitamin
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C per day for 12 weeks. Before and after the 12 weeks subjects were tested on a 12 minute walk /
run test. Afterwards there was a small but insignificant increase in distance covered during the 12
minute test. But, neither of these investigators chose to compare their groups against sedentary
subjects to test if there was any training effect. Keren and Epstein (1980) used a double blind
placebo controlled protocol, but did not see an improvement in aerobic or anaerobic capacity (on
the cycle ergometer) in either control or placebo group, after three weeks of running and hiking
training. Ideally the test of aerobic or anaerobic capacity should be in the same activity in which
participants were training. In an interesting twist van der Beek et al (1990) used vitamin C
restricted diets to show no negative effects upon aerobic power and onset of blood lactate.
However, this might have been more informative if they had compared their subjects to trained
individuals to see if the same effect is seen. Again, we see a variety of different methods to test
the effectiveness of vitamin C but, no clear cut determination of its influence upon muscular
work. But, it is clear that more investigation should be done using trained and untrained subjects
as opposed to one or the other.
Beta-carotene has not been widely studied in relation to its influence upon muscular
work. LeBlanc investigated it in connection to its influence upon 5k race times. They
supplemented with 15 mg beta-carotene or placebo per day for one month. Following a washout
period the groups were crossed over, and it was determined that there was a significant
improvement in 5k race times. Since beta-carotene is located between the lipid bilayers of cell
membranes, it may be more possible that beta-carotene should be taken in combination with
vitamin C and E. A few studies have looked at combination of vitamin C and E together, but
without beta-carotene. Dawson et al (2002) used 15 experienced runners and divided them into
two groups (vitamin or placebo). The vitamin supplement was a combination of 500 mg vitamin
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C and 500 IU vitamin E, or 1000 mg vitamin C and 1000 IU vitamin E. The runners
supplemented for 4 weeks then completed a half marathon run. Afterwards a four week washout
period followed before the subjects were crossed over and received the other capsule for four
weeks. After that second period another half marathon was run. Following each run blood was
collected and analyzed for creatine kinase and malondialdehyde. There were significant increases
seen in creatine kinase (p<0.05) but not malondialdehyde between the vitamin and placebo
groups. Rokitzki et al (1994) used runners in their study in a similar fashion. Subjects were
assigned to either a placebo or vitamin (400 IU vitamin E, 200 mg vitamin C) for 4.5 weeks.
Following supplementation they ran a marathon race. Comparing immediately after the race to
24 hours post race, there were significant increases in creatine kinase in the supplemented and
placebo group. However, the increase in creatine kinase in supplemented subjects was
significantly lower than in the placebo subjects (p<0.01). There were no differences seen in
malondialdehyde levels between the two groups. However, there was no way to know if subjects
were giving an all out effort during the run, as there was no way to quantify the actual work
performed. In the study by Bryant et al (2003) mentioned earlier, the same case can be made.
Although subjects supplemented with vitamin C and E, considering the supplementation protocol
there was no way to determine if lower malondialdehyde levels were a product of training or the
antioxidant combination.
There is no conclusive evidence supporting the ingestion of antioxidant supplements.
Much of the advocacy of supplementation with these nutrients is based upon theoretical ideas. In
table 1.3 we see that there are a number of studies looking at each of the aforementioned
antioxidants. There is no conclusive evidence from these studies that either of the antioxidants
can affect muscular work. There are mixed results for each antioxidant and, most did not use two
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groups of volunteers. They either used trained or untrained subjects but usually not both. In
addition, only one of these studies investigated subjects’ deficiency status for each nutrient, prior
to the supplementation protocol. LeBlanc (1998) investigated subject status for beta-carotene and
discovered that on average, they were on the lower end of the typical beta-carotene intake of
American adults (Henderson et al, 1989).
Finally, none of the studies cited have used the mixture of beta-carotene, vitamin C, and
vitamin E when investigating antioxidant supplementation upon muscular work. Although there
has been no conclusive evidence to support the supplementation of these nutrients, perhaps the
combination of these three may have a significant effect considering their interrelationship
within the cell membrane.
Main Points
1.

No one has compared the effect of beta-carotene, vitamin E, and vitamin C in
combination upon muscular fatigue.

2.

No one has compared the effect of beta-carotene, vitamin E, and vitamin C in
combination after acute and chronic supplementation, while using a double-blind
crossover experimental design.

3.

Few studies compared trained and untrained subjects

4.

The literature is limited concerning the effect of beta carotene upon fatigue and
more research is warranted

5.

As Vitamin C helps to regenerate vitamin E within the cell, via its interaction with
the alpha tocopheroxyl radical, it may be possible that these vitamins may work in
conjunction to affect muscle fatigue during intermittent work
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Project Rationale
Muscular work causes an increase in oxygen consumption and ultimately an increase in
free radicals and other ROS. This increase in ROS can attenuate muscle work capacity and may
cause the cessation of work production altogether if their removal is not prompted in a timely
fashion. Many popular sports involve short bursts of activity followed by a rest period or period
of reduced activity (basketball, track and field, football, tennis), whether during training or in
competition. Since these activities involve these short time periods of activity it may be of
importance to stave off the effects of fatigue, during intermittent time periods of work, than the
overall endurance capacity. With this being the case, any positive effect that antioxidant
supplementation may have upon the improvement of work capacity during these times would
most likely be welcome. Conversely, if the case were that supplementation with these
antioxidants has a negative effect, surely most athletes would not be encouraged to supplement
them in their diets.
Preliminary Studies
In a pilot study conducted in our laboratory we instructed the subjects to perform a
prescribed intermittent work protocol of five sets of 20 arm curl repetitions, with 60 seconds rest.
The rest period was long enough to allow the aerobic energy system to contribute towards energy
production (Astrand, 1986, pp. 304-307) and to ensure that subjects could give an “all out”
effort. Only the last two sets were used to evaluate fatigue. However, supplementation with a
beta-carotene, Vitamin E, and Vitamin C combination resulted in mixed findings. A two-way
factorial (mixed model) ANOVA design with repeated measures, was used for analysis. There
were six untrained and ten trained subjects which resulted in unbalanced groups. However, as
with most statistical software (Freund, 1997, pp. 486), the SAS software accounted for this
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difference in the analysis by using the Proc Mixed procedure. Three conditions were compared:
1) Pre-supplementation; 2) Acute supplementation (one day of supplementation); 3) and 25 days
of supplementation. At p<0.10, there were significant main effects for subjects’ status (trained or
untrained) (p=0.10), the interaction of status and supplemental state (p=0.05), and the interaction
of supplemental state and the day (pre, acute, 25 days) (p=0.09). In figure 1.2 we see slightly
lower work, in acute as compared to chronic supplementation in trained subjects. In untrained
subjects we see (figure 1.3) an increase from pre to acute, and an increase from acute to chronic
supplementation with regards to work. Although the results seem to be mixed, it may be that
chronic supplementation with the antioxidant mixture may have a positive impact upon work in
the untrained subjects. Unfortunately, subjects dietary status for the antioxidants is not known. It
may be possible that the untrained were below the safe intake levels of one or more of the
antioxidants, and that possibly this may affect muscular fatigue during intermittent work With
this information it may be more conclusive to conduct a study with a larger number of subjects
using a crossover design, in which subjects are able to supplement on both placebo and the
antioxidants. In addition, having knowledge of the subjects average dietary intake for the
antioxidants would give a more clear picture of their body status for the supplements.
Problem Statement
The purpose of this study is to investigate the effect supplementation with an antioxidant
mixture of beta-carotene, vitamin E, and vitamin C, will have upon work capacity in trained and
untrained subjects.
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Figure 1.2 Work measures after supplementation with either placebo or antioxidant mixture of
beta-carotene, vitamin C, and vitamin E in trained subjects.

Objectives

1.

To examine whether supplementation with an antioxidant vitamin mixture will affect
fatigue in exercising muscles, in normal healthy untrained subjects

2.

To examine whether supplementation with an antioxidant vitamin mixture will affect
fatigue in exercising muscles, in normal healthy arm trained subjects

3.

To examine whether there is a difference in the effect of supplementing antioxidant
vitamins upon normal healthy untrained subjects, when compared to arm-trained subjects
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Figure 1.3 Work measures after supplementation with either placebo or antioxidant mixture of
beta-carotene, vitamin C, and vitamin E in untrained subjects.(Note: n=1 for placebo)
Hypothesis
It is expected that there would be a group by condition interaction (p<0/10) such that
acute (one day) and chronic supplementation (28 days) with the antioxidant mixture (betacarotene, vitamin C, vitamin E) would result in a decreased rate of fatigue in the untrained as
compared to the placebo, but not in the trained. Additionally, while empirical, it is also expected
that a greater quantity of work will be observed in the untrained following chronic
supplementation when compared to acute supplementation, but that this would not be evident in
the trained subjects.
Limitations / Delimitations
Because of the proximity of the subject pool at the university, the age of our subjects will
be age 18 to 30. Therefore, the results may not be applicable to the ages outside this population.
A food diary will be used to assess group antioxidant status, and accuracy of those diaries will be
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dependent upon subject compliance. Only serum vitamin C will be measured from blood
samples. Due to the multifaceted aspects of fatigue (i.e. neuromuscular, CNS, muscular blood
flow, calcium availability, etc.), altering one aspect may not cause a sufficient detectable change
in work measures. Finally, the exercise protocol will involve performing arm curls on the
dynamometer, thus the results may not be applicable when discussing other exercises or other
muscle groups.
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Table 1.3 Previous Studies Using Antioxidants
Author

Exercise
Mode

Nutrient

Result

Placebo
Controlled

Subjects

LeBlanc 1998

outdoor
running

beta-carotene

improved 5K race
time

yes

trained
runners

Novelli 1990

swimming

vitamin E

increase exhaustion
time

yes

Mice

Sumida 1988

cycle
ergometer

vitamin E

no difference

no

healthy
male
volunteers

Lawrence 1975

swimming

vitamin E

no difference

yes

trained
swimmers

Spioch 1966

step test

vitamin C

decrease in O2
consumption, debt,
and pulse rate

no

healthy
male
volunteers

Samanta 1985

9-minute walk
/ run

vitamin C

improved walk
distance

yes

physically
active
students

Gey 1970

12 minute run

vitamin C

improved run
distance (less than
1%), not statistically
sig.

no

air force
officers

Keren 1980

cycle
ergometer

vitamin C

no improvement in
VO2 max

yes

untrained
subjects

Allesio 1997

cycle
ergometer

vitamin C

higher oxidative
stress in placebo

yes

healthy
subjects

Sacheck 2000

downhill
running

vitamin E

low vit E vs high vit
E: No change in
Oxidative stress

no

trained
rowers

van der Beek
1990

cycle
ergometer

vitamin C

low vit C vs suppl vit
C: no change in
VO2max or OBLA

yes

healthy
subjects

Bryant 2003

cycle
ergometer

vitamin C and
E

lower lactic acid (not
sig.): higher
malondialdehyde in
vit C compared to
placebo

yes

trained
cyclists

Dawson 2002

half marathon
run

vitamin C and
E

no difference
between groups in
CK, myoglobin,
malondialdehyde

yes

trained
runners

Lang 1986

run to
exhaustion

vitamin C

improvement in
endurance capacity

yes

guinea pigs
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Chapter 2 Methods
Subjects
Thirty-one healthy subjects, both male and female, were recruited from student
populations at a local university, and at a local health club. Of those volunteers only ten
completed the entire protocol (see the next chapter for details). None of the participants were
currently taking medication, nor were they currently supplementing with antioxidant vitamins.
Informed consent was obtained from each subject.
The subjects were assigned to one of two groups: a trained group (Tr); and an untrained
group (Untr). Untrained were defined as individuals who did not currently participate in any arm
resistance training activities. Trained subjects were those who were currently participating in an
arm resistance training program at least one day per week. In addition, trained subjects must
have been training for a minimum of one year. Each subject compiled a 3-day food diary to
assess antioxidant vitamin status, and underwent an initial arm curl exercise protocol on the
dynamometer, as a practice run, before supplementation. This allowed each participant to
become accustomed with the requirements of the subsequent exercise tests.
Supplementation Protocol
Before the supplementation protocol began, each subject compiled a 3-day food diary to
assess antioxidant vitamin status. The diary length was selected based upon previous research
that showed that beyond this time period, the quality of record keeping declines (Gersovitz et al,
1978; Lee and Nieman, 2003;). Subjects’ diaries were assessed for RDA levels of the selected
vitamins using the software Food Processor for Windows (version 7.30) by ESHA Research.
This allowed estimation of the extent to which the RDA for the selected antioxidants was being
met, or exceeded, in the regular diet.
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Subjects ingested either one antioxidant capsule consisting of 25,000 international units
(IU) of vitamin A in the form of beta-carotene, 400 IU of vitamin E, and 500 milligrams (mg) of
vitamin C, or one placebo capsule. The provided capsule was ingested at the same time of day
for 28 days following the initial pre-supplementation fatigue test. The antioxidant capsules were
produced by Vitamin World, Inc. according to the standards of the United States Pharmacopeia /
National Formulary requirements. After supplementation, subjects underwent a 28 day washout
period to allow antioxidant levels to return to normal. At this point, the capsules were crossed
over, and each individual ingested the other tablet for 28 days. All subjects were given a 28 day
supply of capsules at the beginning of each supplementation period, and compliance was
ascertained by the number of capsules remaining at the end of each specific supplementation
period.
Exercise Fatigue Testing Protocol
The exercise fatigue testing procedure consists of an initial practice test using a Biodex
dynamometer, and subsequent tests at Day-1 and Day-28 of each supplementation period. The
subjects were unaware that the first session (the preceding the supplementation period) was not
being recorded. For each of the subsequent tests, each subject was tested within a 12-hour range
of the original test. For example, if the original test was at noon, then the tests at Day-1 and Day28 were between 6:00 a.m. and 6:00 p.m. on those days. The exercise protocol consisted of
seven sets of arm curl exercises, using the non-dominant arm, with a1-minute rest between each
set. One set consisted of 20 repetitions. The speed of movement was set at 60 degrees per
second for flexion, and a maximum of 400 degrees per second for extension (this speed allowed
subjects to relax on the eccentric phase). The subjects were instructed to give all out effort for
each set. Subsequently, total work (force multiplied by distance) for each set was measured by
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the dynamometer, and used as the measure of fatigue. Only the total work from the last three sets
was used in determining fatigue.
Blood Analysis.
Serum vitamin C levels were assessed during the washout period and one day before the
end of the second supplementation period. Vitamin C was assessed using the method developed
by Dr. Richard Tulley (Tulley, 1992) in which serum samples are analyzed using the Beckman
CX5 clinical chemistry analyzer. Each subject had blood samples drawn at the end of the
washout period and one day before the end of the second supplementation period. Blood draw
and analysis were performed at the Pennington Biomedical Research Center, Baton Rouge,
Louisiana.
Data
Total work for each set was collected for each subject, for each supplementation phase.
Thus, each subject performed seven sets of the exercise on five separate occasions. Only the last
three sets of the last four sessions, however, were used in the fatigue calculations. To examine
the effect of supplementation upon fatigue, the total work of the last three sets was summed, and
used for statistical comparison and analysis using the SAS statistical software.
Power Analysis
In order to determine sample size a power analysis was carried out by the SAS software.
In consultation with Mr. Xiaobing Fang (M.S., Experimental Statistics, Louisiana State
University) it was decided that, because more than one main effect was to be considered, power
for the study would be determined by the method described by Kuel (2000, pp. 63):
The power of a test of hypothesis is the probability of rejecting a false null hypothesis.
The statistics Fo =MST/MSE is used to test the null hypothesis Ho: Ji = 0. The power of
the test is 1 – $ = P(F > F ", <1, <2 | Ho false), where <1 and <2 are the numerator and
denominator degrees of freedom, respectively. When Ho is false, Fo has the non-central F
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distribution and non-centrality parameter. If the null hypothesis is true, then the noncentrality parameter is zero and Fo has the central F distribution.
Based upon this method a SAS program was designed to estimate sample size with the target for
power the interaction of supplement and time at 0.70 (Appendix B)(the program gives a number
of sample size, alpha level, and power combinations). Based upon this calculation it was
determined that for a power = 0.8, and an alpha level = 0.10, there would be 28 subjects required
for the later study. The final study will be a crossover design as opposed to the pilot study. This
may allow for less variation than the original study.
Statistics
Following data collection all results will be analyzed and compared for significance. A
mixed model two-way repeated measures ANOVA with an alpha level of p<0.10, was used to
compare within and between group differences in the work measures. The repeated measures
will be acute placebo, chronic placebo, acute vitamin, and chronic vitamin. For the serum
vitamin C measures a paired t-test will be used to compare placebo and supplementation phase
vitamin C levels.
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Table 2.1 Timeline For the Study
Days 1-7

Subjects record diet for three days. At the beginning of the
recording period, subjects will have the initial assessment on
the dynamometer.

Day 14 and 15

Subjects begin the supplementation period. On the second day,
they will again be assessed on the dynamometer.

Day 42

Subjects continue supplementation, and on the twenty-eigth
day are assessed on the dynamometer

Day 44 - 70

Subjects undergo washout period

Day 71 and 72

Subjects begin the second supplementation period. On the
second day, they will again be assessed on the dynamometer.

Day 100

On the last day of supplementation, subjects will again be
assessed on the dynamometer
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Chapter 3 Results
Subjects
The study originally began with 31 subjects. Out of that group 20 completed the first
supplementation phase, but did not participate in the crossover. Ten subjects completed the entire
study and participated in both phases. Subjects were selected from kinesiology courses at the
university. The mean age of all subjects was 20.9 years with a maximum of 23 years and
minimum of 19 years (Table 3.1). All completed a statement of informed consent (Appendix D).
Each subject completed a twenty-eight day supplementation period followed by a
one month washout period then, followed by another twenty-eight day supplementation period.
They were instructed to pick up their packet of twenty-eight capsules one week prior to the
beginning of each supplementation period. There were two packets - one containing the placebo,
and the other the antioxidant mixture. Because the study was double blind, neither the
investigator nor the subjects had knowledge of the contents of the packet that each received at
the specified intervals.
Table 3.1 Subjects Descriptive Statistics
N

Mean

Std Dev

Std Err

Max

Min

10

20.90

1.101

0.348

23.00

19.00

Food Diary Measures
Subjects completed a 3-day food diary to assess current intake for the antioxidants being
ingested. The information therein was analyzed using the software, Food Processor for Windows
(version 7.30) by ESHA Research, as described earlier. The results for each subject are listed in
table 3.2. The means for each antioxidant are listed for each subject for the three day period.
Descriptive statistics were calculated and appear in table 3.3.
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Table 3.2 Antioxidant Vitamin Measures From Food Diary Data
Subjects

Status

Beta-car.
(mcg)

Vitamin C
(mg)

Vitamin E
(mg)

1

Trained

811.12

98.42

2.68

2

Untrained

498.62

87.89

5.30

3

Trained

3122.46

1017.19

14.56

4

Untrained

1388.48

63.19

4.21

5

Untrained

330.18

99.37

3.98

6

Trained

9.38

31.12

4.96

7

Trained

574.32

107.25

8.50

8

Untrained

223.93

102.29

1.58

9

Trained

7494.26

31.42

2.72

10

Trained

3461.40

118.31

18.29

Table 3.3 Descriptive Statistics for Antioxidant Intakes
Nutrient

N

Mean

Std Dev

Std Err

beta-car (mcg)

10

1791.415

2336.351

738.819

vitamin C (mg)

10

175.645

297.277

94.007

vitamin E (mg)

10

6.678

5.539

1.752

Serum Vitamin C Levels
Subjects were asked to volunteer to give blood samples during the 27th day of each
supplementation phase. Blood samples were analyzed for vitamin C content at the clinical
chemistry laboratory at the Pennington Biomedical Research Center in Baton Rouge, Louisiana.
A 5.0 milliliter sample was collected from each subject at each blood draw. Samples were
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analyzed using a Beckman Synchron CX5 Chemistry Analyzer. The method is the same
described by Tulley (1992) and currently used at Pennington.
Eight of the ten subjects volunteered to have their blood analyzed. Table 3.4 lists the
results of the blood sample analysis for each subject. As indicated, blood was drawn one day
before the end of each supplementation protocol. Each subject had one sample taken while on the
placebo and one taken while on the antioxidant mixture.
Table 3.4 Vitamin C Sample Results
Subject #

Placebo

Vitamin C

1

13.20

16.30

2

10.40

11.40

3

6.10

23.60

4

10.50

17.40

5

8.20

9.30

6

9.20

9.40

7

4.70

6.20

8

2.30

12.10

Following vitamin C data collection, a statistical analysis was performed to obtain
descriptive statistics and to observe any differences between the two supplementation periods. A
paired t test was chosen to describe any differences. Table 3.5 lists the descriptive statistics for
the vitamin c samples.

Table 3.5 Vitamin C Samples Descriptive Statistics
placebo
vitamin

N

Mean

Std Dev

Std Err

8
8

8.075
13.213

3.535
5.587

1.250
1.975

Results of the paired t test are presented in table 3.6, and show significant differences
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(p=0.046) between samples taken while subjects were on the placebo compared to those took
while subjects were on the antioxidant mixture. Results of the paired t test show that serum
vitamin C levels increased following the antioxidant supplementation when compared to the
placebo samples.
Table 3.6 Vitamin C Samples Paired T-Test
Mean

Std Dev Std Err

placebo

8.075

3.535

1.250

Vitamin

13.213

5.587

1.975

Mean Diff T Value Prob

DF

-5.138

7

-2.418

0.046

Arm Curl Exercise Measures
Following the arm curl exercise, work achieved for each set was recorded in joules for
each subject. Table 3.7 shows the results for each subject at each phase of supplementation. The
protocol was performed on a Biodex dynamometer in the kinesiology lab at Louisiana State
University. Figure 3.1 indicates the acute vitamin condition was 4% lower when compared to
the chronic vitamin condition, in the trained subjects. The untrained subjects were 3% lower
from the chronic placebo compared to the acute vitamin condition, and a 7% from the acute
vitamin compared to the chronic vitamin condition (Figure 3.2).
A two-way repeated measures ANOVA was performed to detect any differences. The
ANOVA results are listed in table 3.8. There was no significant difference for the main effect of
suppstatus (acute placebo, chronic placeboe, actute vitamin, chronic vitamin)( p=0.90).
Additionally, there was no significant effect for the interaction of training and suppstatus
(p=0.95). There was, however, significant differences for the main effect of training (train vs.
untrain) (p=0.07). Power for all tests are low and indicate a high possibility of making a Type II
error (Table 3.9). Power was determined by the SAS software (Appendix C) using the method
described by Kuel (2000, pp. 63).
52

Table 3.7 Work Measurements for Each subject
Subject

Acute Plac

Chronic Plac

Acute Vit

Chronic Vit

training

1

1006.00

1768.50

1877.80

2262.70

trained

2

773.40

616.70

1096.10

789.30

trained

3

2489.00

2780.10

1854.60

1577.20

trained

4

1819.40

2400.40

3007.80

2787.30

trained

5

1372.20

1046.90

1347.10

1199.40

trained

6

752.10

1271.40

1359.40

1489.60

trained

7

1042.50

1089.60

1267.20

1037.60

untrained

8

2101.70

2425.50

1834.20

1800.50

untrained

9

966.60

844.30

1078.80

1159.20

untrained

10

504.60

616.30

670.60

528.40

untrained

To summarize, it appears that the supplementation protocol did not have a significant
impact upon work output although there is a significant main effect of training (p=0.07). Clearly,
no statistically significant change in work output was seen under either condition, trained or
untrained. Additionally, power is too low to make a decision without risk of Type II error,
regarding the research hypothesis.
Table 3.8 Two Way Repeated Measures ANOVA for Work Results
Source

DF

SS

MS

F

Pr

train

1

1765764.150

1765764.150

3.62

0.07

suppstatus

3

274571.469

91523.823

0.19

0.90

train X
suppstatus

3

180431.321

60143.774

0.12

0.95

error

32

15604409.30

487637.79

total

39

17922768.64
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Table 3.9 Power Measurements at Alpha = 0.10
Effect

Power

train

0.476

supp

<0.10

trainX suppstatus

<0.10

Trained Subjects
2500

joules

2000
1500
1000
500
0
tr acute pla

tr chron plac

tr acute vit

Supplementation Status
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tr chron vit

Figure 3.2 Work Output for Untrained Subjects

Untrained Subjects
2000

joules

1500
1000
500
0
untr acut pla

untr chron pla

untr acute vit

Supplementation Status
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untr chron vit

Chapter 4 Discussion
Antioxidants are continuously marketed to athletes and fitness enthusiasts as being
beneficial to muscular performance (ADA, 2000). This is because there is a concomitant increase
in oxygen consumption during muscular work which results in an accompanying increase in free
radicals and other ROS. Nevertheless, the human body has developed a system of enzymatic and
non-enzymatic antioxidants that help to protect it during “steady state” (Powers and Hamilton,
1999; Powers and Lennon, 1999) . However, during times of increased work these systems may
be overwhelmed and impair the ability of a muscle to sustain a given level of work production.
Studies have investigated the possibilities that supplementing exogenous antioxidants
beyond the RDA for those nutrients that may have a beneficial effect against the deleterious
consequence of an increase in ROS. These antioxidants, beta-carotene, vitamin E, and vitamin C
have been studied individually in exercising subjects with mixed results.
This investigation supplemented subjects with a combination of these three antioxidant
nutrients in an attempt to answer questions regarding their affect upon muscular work. Very few
studies have investigated these substances together, and none have used a protocol similar to the
one used in this study. Based upon previous literature and the pilot study mentioned earlier, this
more thorough investigation was carried out. To this end it was decided that an intermittent work
protocol using trained and untrained subjects, who were not deficient in any of the tested
antioxidants was the ideal design.
Food Diary Measures
Vitamins C and E, and beta-carotene intakes were estimated using 3-day food diaries.
Each subject was given a diary to completely record everything that was eaten during a 3-day
period. As invasive measures of these two of the nutrients were not investigated, it was
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determined that recording daily intake of these nutrients would provide the best estimate of tissue
levels for this particular group. Assessment of the subjects’ status in regards to the antioxidants
studied, was necessary to ensure that there were none of them starting from a point of deficiency,
prior to the start of the experiment.
Currently there is no RDA for beta-carotene in humans. However, the RDA for vitamin A
is 0.8 - 1.0 retinol equivalents (RE) (Groff et al, 1995). Beta-carotene is a precursor to vitamin A,
and is often called pro-vitamin A. The body cleaves stored beta-carotene as needed to maintain
serum vitamin A levels within the body. There appears to be no serious side effects when
ingesting beta-carotene in excess of the RDA for vitamin A because it is not converted to vitamin
A until the body needs it.
Following diet analysis for each subject, the software displayed information for each
vitamin and mineral with an RDA and also other nutrients, such as beta-carotene, that do not
currently have an RDA. The Food Processor for Windows software reported total vitamin A /
provitamin A in the diet. It also provided beta-carotene content as a separate measure from total
vitamin A content. Our subjects mean intake for beta-carotene during the 3 days of listing food
intake was 1791.415 mcg (Table 3.3). Six micrograms of beta-carotene is equal to one RE.
Again, this measure was just a part of the total vitamin A intake, but it does illustrate the extent
to which the subjects were meeting the RDA for vitamin A. On average the subjects ingested
298.57 RE per day for the three day period. This far exceeds the RDA for vitamin A and ensures,
barring any malabsorptive disorders (pancreatic, liver, or gall bladder diseases), that the subject
pool was not vitamin A deficient prior to the supplementation regimen (Beta-carotene ingestion
for each subject is listed in table 3.2).
The RDA for vitamin E is 8 mg and 10 mg tocopherol equivalents (TE) per day, for
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women and men respectively. The normal intake for vitamin E in American diets is 4 mg TE to
22 mg TE/day for individuals not supplementing their diet with exogenous vitamin E (Di Mascio
et al, 1991). Again, vitamin E requirements increase as the intake of PUFA increases or
decreases. Because of this dependency upon PUFA content, determining a precise requirement
for vitamin E has been difficult. However, because most foods high in PUFA are also high in
vitamin E, there is not much fear of deficiency. In fact, vitamin E deficiency in humans is very
rare. As in the case with beta-carotene, deficiency in adults is only seen in those suffering from
malabsorption diseases, especially those that affect the absorption of fats.
The diet analysis determined that the mean intake for vitamin E for each subject for the
three day period was 6.678 mg TE/day (Table 3.3). This is just below the RDA for vitamin E but
is well within the normal intake for those consuming a typical American diet (Di Mascio et al,
1991). This also falls between the range stated by Guthrie and Picciano (1995), between 5 and 20
mg TE/day, that would be considered safe depending upon PUFA intake. Considering the rarity
of vitamin E deficiency, and the fact that our subjects intake of vitamin E falls between the range
for normal intake, it is highly unlikely that these subjects were vitamin E deficient before
beginning the supplementation regimen.
The RDA for vitamin C is 60 mg/day for adult men and women. This amount was chosen
based upon the amount required to maintain a body pool of 1500 mg (the amount of vitamin C
that can be held within the body without excretion via the kidneys). The subjects’ food diaries
showed that the mean intake for each subject per day was 175.645 mg of vitamin C per day
(Table 3.3). This number exceeds the amount in the RDA, but is far below the amount indicated
in vitamin C toxicity (Alhadeff et al, 1984). Again, it is highly unlikely that subjects were
vitamin C deficient before beginning the supplementation protocol.
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Serum Vitamin C Levels
Blood samples were collected from each subject on the 27th day of supplementation, and
subsequently analyzed for serum vitamin C levels. Serum vitamin C analysis was carried out at
the Pennington Biomedical Research Center clinical chemistry laboratory, as previously noted.
Each subject was tested while supplementing on both placebo, and vitamin C. While on the
placebo, mean serum vitamin C levels (Table 3.5) were 8.075 mg/L, which is well within normal
values (5 - 15 mg/L) for adequate vitamin C status (Tietz, 1997). Following the 28 day vitamin C
supplementation period (which followed a twenty-eight day washout period) mean serum
vitamin C levels increased to 13.213 mg/L. The subsequent paired t-test for differences showed a
significant difference between placebo and vitamin C periods (p=0.046)(Table 3.6).
Clearly the supplementation of exogenous vitamin C was well tolerated, and had an affect
upon subjects’ serum vitamin C. The increase in serum vitamin C tends to support the
absorbability of the chosen supplement which, as was indicated, fully complied with United
States Pharmacopeia / National Formulary requirements. It also supports that supplementing with
vitamin C increases plasma vitamin C levels (Polidori et al, 2004).
The increase in vitamin C also gives insight into the status of another antioxidant used in
this study. As long as the levels of serum vitamin C are at or above normal levels we can expect
vitamin E to act as an antioxidant rather than a pro-oxidant. Only when vitamin C levels are
below normal can we expect a reduction in vitamin E levels because of ascorbate’s crucial role in
regenerating the alpha-tocopheroxyl radical (Kontush et al, 1996; Brown et al, 1997; Chan,
1993). As we have seen vitamin C levels increase significantly, we feel confident in the fact that
vitamin E and beta-carotene was well tolerated, and increased the total body pools of both in
each subject.
59

Power and Significance
During this study there were a number of subjects who dropped out at various points
throughout the protocol. The study began with thirty-one subjects and ended with ten who
completed the entire protocol. Since sample size is one of the factors affecting power (Norton
and Strube, 2001; Thomas and Nelson, 2001;) any loss in subjects will have a profound effect
upon power. Power allows for a level of confidence that the decision to be made from statistical
results is the correct decision, or more simply put, it is the probability of not making a Type II
error (failing to reject the null hypothesis when it is false) (appendix E). The power analysis for
this study revealed extremely low power for the main effects as well as their interaction. Power
for supplementation status, training, and their interaction was <0.10, 0.35, and <0.10
respectively. Therefore, due to the the loss of power in the study, we cannot have confidence
that we would not make a Type II error if we were to accept the null hypotheses. The low power
almost guarantees making a Type II error.
Variability is another factor that may affect power. Each of the main effects, and the
interaction have large variances in this study. For instance, if the distribution of scores were
represented by a curve, the narrower the curve is the smaller the variability about the mean;
conversely, the wider the curve the greater the variability about the mean (Norton and Strube,
2001). If there were a pair of distribution of scores on the scale, the wider the range of scores the
more overlap there would be between the two curves. If one of those curves represents the
assumption that the null hypothesis is true and the other represents the distribution based upon
the research hypothesis being true, the more overlap there is between the scores the less chance
there is of detecting a real difference. As the overlap becomes larger beta increases and thus, 1 beta, or power, decreases. As the main effects and interaction variances are large in this study
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(appendix C) the variability, as well as the number of subjects, has also had an effect upon the
power of this study. In addition, the variability makes the reproducibility of this study very
difficult under the same conditions. Consequently, it is with these facts in mind that we will
report the results and any inferences that may be taken from them.
Acute Supplementation Work Values
Subjects were supplemented with a placebo and the antioxidant vitamin mixture (betacarotene, vitamin E, and vitamin C) to see if an acute dose would cause an affect upon the work
capacity during the arm curl protocol. As was noted, there is scant research investigating the
affect of an acute (one day) ingestion of either of the three antioxidant nutrients upon muscular
fatigue during the arm curl protocol prescribed in this study. In addition, no studies using the
intermittent arm curl protocol were found throughout the literature.
Neither untrained nor trained participants showed a significant difference in work values
from the acute placebo to chronic placebo phase (untrained p=0.86; trained p=0.49). Nor were
there any significant differences between the chronic placebo and acute vitamin phase (untrained
p=0.95; trained p=0.79). The chronic placebo was 3% lower when compared to acute vitamin
phase, and the acute vitamin was 7% lower when compared to chronic vitamin phase in work
output. However, with the significance level and power of the analysis we cannot make a
conclusion about this and have little confidence in the decrease seen in these work values. Again,
the unanticipated dropout rate of the subjects have resulted in the low power of the test, and
make it highly likely to commit a Type II error (appendix E).
Chronic Supplementation Work Values in Untrained
Chronic supplementation work values in untrained subjects were compared following the
supplementation period. As in the case of the acute supplementation, scant research exists that
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compares the influence of this antioxidant mixture upon muscular work capacity during an
intermittent work protocol. In the untrained subjects no significant difference in work was
observed from the chronic placebo supplementation to the acute vitamin supplementation
(p=0.95), nor from the acute vitamin to chronic vitamin supplementation (p=0.87). Once again
we cannot have any confidence in a determination to make because of the low power of the
statistical analysis. So, although the p values would indicate that we should fail to reject the null,
the power does not allow for there to be any confidence in that decision.
Chronic Supplemenation Work Values in Trained
In the trained subjects, no significant difference in work was observed from the acute
vitamin to chronic vitamin supplementation (p=0.86). In a trend seen similar to that in the acute
work values, acute vitamin was 4% lower compared to the chronic vitamin phase in the trained
group. Again, normally at the current p value, we would fail to reject the null. However, the low
power indicates the high probability for Type II error. So, we would have no confidence in
making that determination. Although there may be a trend seen, this would make any percent
changes in work statistically meaningless.
Main Effects and Interactions
When comparing the main effects for trained vs the untrained state there is a significant
difference observed (p=0.07) which, was not unexpected. We would expect the trained subjects
to have higher work values than untrained subjects simply because of their constant training state
throughout the investigation.
For the interaction of the supplement status (acute placebo, chronic placebo, acute
vitamin, chronic vitamin) and training (trained, untrained), p=0.95 (table 3.8). It was
hypothesized that there may be a significant interaction between the two however, p value
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indicates no significance. Additionally tables 3.1 and 3.2 graphically show no apparent
indication or trend towards an interaction between the two states (trained or untrained) under any
of the four supplemental phases.
Antioxidant Status
Much of the research in this area has been observing the influence of single antioxidants
upon work capacity rather than the antioxidant mixture (beta-carotene, vitamin E, vitamin C)
employed in the present study. However, also of note, was the lack of data concerning the
antioxidant nutrient status of subjects before participation in said studies. Some lacked the
information altogether (Spioch et al, 1966; Gey et al, 1970; Keren and Epstein, 1980; Allesio et
al, 1997; Novelli et al, 1990; Sumida et al, 1988; Lawrence et al, 1975), and one reported that
subjects were deficient in the selected antioxidant (LeBlanc, 1998) before supplementation
began. In this study, there was an effort to establish that each subject was not deficient in any of
the supplemented antioxidants (Table 3.2) before beginning the supplementation period.
Descriptive statistics for each nutrient for each subject were analyzed and showed deficiency to
be unlikely in the subject pool. This was performed to ensure that any differences observed were
not caused by a subject’s being deficient in any of the antioxidant nutrients. The ADA and
American College of Sports Medicine report that most athletes do not require supplementation of
vitamins and minerals above the current RDAs (ADA, 2000). This is because most athletes are
consuming a larger amount of food than normal healthy individuals. This high intake usually
ensures that they are not deficient in most nutrients. It is more than likely that our trained
subjects would fit this profile. The exception is made in the case of those athletes who “restrict
energy intake, eliminate one of the four food groups from their diet, or consume high
carbohydrate, low micronutrient-dense diets”.
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Limitations and Other Concerns
There are a number of pitfalls that may have hampered the ability of the current study to
detect differences and obtain sufficient power. First would be the unexpected drop out rate of the
participating subjects. There is no apparent reason for the high attrition rate that is seen in this
study. In previous pilot work the unusually high attrition rate was not observed and there was no
indication that it would transpire here. Subjects used in the current study were university
students. Based upon some of the motivational techniques recommended in Appendix F, I
arranged, with their professors, for the subjects to receive extra points toward their final grade in
the class that I drew them from (they were drawn from a pool of four classes at the university).
As it turned out, many of the students dropped the class they were in and thus, dropped out of the
study. Some students forgot about their appointment date in the lab and were dropped. Clearly,
this has had the largest impact upon the study.
Still those that participated were instructed to give an all out effort on each set of arm
curls. If they did not give the effort required this may also have an effect upon the results. If
subjects are just “going through the motions” it would make it difficult to see any changes in
work values over the four trials. This may be a result of lack of motivation or boredom. Perhaps
having meetings at different times throughout the study could have served as a time to renew
motivation that may have waned since the start of the study (Appendix F).
The subjects were instructed to take the capsules everyday with a meal. However, there
was no way of knowing if they actually followed this advice. It is conceivable that some students
missed days and attempted to “double up” by taking their missed dosage and their scheduled
dosage at the same time. If this were done on more than one occasion by more than one subject
this may have an effect upon the work values as well because of the antioxidant levels that are
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affected.
The subjects in the study were found to be at the normal intake for the antioxidants after
food diaries were measured. Upon observation it may have been beneficial to look at subjects
who were restricted in their diet. Those athletes / individuals who are more likely to have a
restrictive diet (i.e. middle distance runners or swimmers ) may have shown more of an effect
under the intermittent work protocol that was used here. Those who are more prone to restrict the
intake of PUFA or fruits and vegetables may have exhibited a lower than normal intake of
vitamin E and / or vitamin C. We used college students who were either engaging in strength
training regularly or who did no strength training at all. However, none were preparing for a
competition as an athlete would, and so they did not exhibit the kind of restrictive diet that the
aforementioned athletes may. Finally, and perhaps most importantly, we trusted that the subjects
completed their food diaries accurately and truthfully. If they did not this may also have had an
effect upon the outcome of the study. The fact that analyzing serum vitamin E and / or betacarotene levels was financially beyond the scope of this study, was a limitation that we were well
aware of. It may be that these measures would have told a different story concerning subjects
status for the selected antioxidants.
The exercise protocol chosen may not elicit a large enough oxidative stress to see the
results that were anticipated. Arm curls involve mainly the biceps brachii. Perhaps had the
protocol involved knee extensions or leg presses this would have caused a high enough oxygen
demand to observe an affect of the antioxidants. In the future this should be considered when
examining these supplements in a similar manner.
As has been discussed, fatigue is a very complex concept in regard to the human body.
There are many factors that can contribute to fatigue including physiological and psychological
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(Astrand, 1986) components. Among those previously mentioned are substrate depletion
(depending upon the intensity of the exercise), muscle oxidation-reduction state, psychological
state / mood, CNS fatigue, and local blood flow.
This study set out to investigate the effect supplementation with the beta-carotene,
vitamin C, and vitamin E would have upon work capacity during an intermittent work protocol
of seven sets of arm curls with one minute rest between each set. As oxidative stress has shown
to play a part in muscular fatigue (Reid, Hack et al, 1992; Novelli et al, 1990) the theory was that
supplementing with these antioxidants would help to affect the amount of work being produced
through their neutralizing some ROS. Nonetheless, it may be possible that indeed they did help
neutralize some of the ROS, but perhaps that the effect is so small as to not make a noticeable
difference. To measure this effect, determining the work using the dynamometer may not be the
best method. Perhaps another invasive measure unknown to this investigator is available to
determine this effect.
As this study involved the arm curl protocol and the measurement of work by the
dynamometer, there was no way to address the possibility of there being a psychological factor
contributing to fatigue. The protocol was not set out to evaluate psychological factors
contributing to fatigue. It may be possible that psychological factors have played a part in this
study. As mentioned earlier mood, plays a large part in fatigue. If subjects were not in a good or
“energetic” mood, or had feelings of depression this may have had an effect upon the results of
their tests on the dynamometer. Unfortunately, this cannot be accounted for under the conditions
set forth.
Neural fatigue was not evaluated during this study. Although it seems unlikely that CNS
fatigue was a factor, according to the results by Merton (1954), there was not a way to evaluate
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this on the dynamometer in the laboratory. However, this type of fatigue would more than likely
be measured with an EMG. This is available in the university laboratory and should be
considered for the future when a study of this undertaking is being considered. In addition, blood
flow was not evaluated under the current study conditions. Although, this measure would
probably be determined with some kind of blood flow occlusion device (similar to a blood
pressure cuff). However, this seems unlikely as this kind of device may have created more of an
oxidative stress than without.
It is unfortunate that this study had such a high attrition rate and thus, low power. In the
future there are some suggestions to enhance the chances of having a larger power measurement.
Perhaps an increase in the number of subjects in the study, or longer supplementation period
would help to guard against the high attrition rate, or allow a stronger effect of the supplement.
Also, an increase in the number of subjects from a more diverse population or specialized
population (i.e. diet restricted athletes, the elderly, all women, etc.) will shed more light upon the
possibilities. Subjects were primarily college age students from a university population. If
subjects were taken from a wider age range and a larger pool we may see significant differences.
For this study we used the population that was most accessible. It may be that this trend would
not prove to be significant with these changes. However, if it were found to be significant this
would give some validity to the notion that supplementation with exogenous antioxidants is not
only of no benefit but, possibly detrimental to muscular performance during exercise.
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Chapter 5 Summary and Conclusions
The purpose of this study was to investigate the possible effect that supplementation with
a mixture of beta-carotene, vitamin C, and vitamin E may have upon fatigue, during a protocol of
intermittent work. Exercise has been shown to increase the proliferation of free radicals and ROS
within working muscles due to an increase in oxygen consumption (Powers and Hamilton,
1999). The antioxidants beta-carotene, vitamin C, and vitamin E have been shown to neutralize
some ROS within tissue cells. Manufacturers market these antioxidants as being necessary to the
general public, but also to athletes and fit individuals specifically (ADA, 2000). Although
research has shown that athletes usually ingest more than the RDA for most nutrients through
their diet alone, the supplementation of antioxidants is still promoted by these manufacturers.
It has been demonstrated that the proliferation of ROS during muscular work can
contribute towards fatigue in working muscles (Reid and Haack, 1992). To this end, investigators
have attempted to test if supplementation with non-enzymatic antioxidants would have an effect
upon muscular work. Results have been inconclusive, and have not looked at how combining the
three selected antioxidants (beta-carotene, vitamin C, vitamin E) may influence muscular work.
Therefore, this study was designed to investigate the following hypothesis:
There would be a group by condition interaction (p<0/10) such that acute (one day) and
chronic supplementation (28 days) with the antioxidant mixture (beta-carotene, vitamin
C, vitamin E) would result in a decreased rate of fatigue in the untrained as compared to
the placebo, but not in the trained. Additionally, while empirical, it is also expected that a
greater quantity of work will be observed in the untrained following chronic
supplementation when compared to acute supplementation, but that this would not be
evident in the trained subjects.
Results indicated that there was no effect of the antioxidant supplementation protocol
upon muscular work during the intermittent work regimen. There was a significant effect of
training as was expected (P=0.07), but not with the interaction of training and supplementation
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(P=0.95). Unfortunately, because of the low power of this study, we cannot place any confidence
in a determination made about the hypothesis.
In the future, investigators may want to look at how a longer period of supplementation
influences work capacity. Most athletes would not take these supplements for just a 28 day
period as in this study. Many would take it over the course of an entire competitive season. In
addition, what would be the dose response? Is the RDA of each nutrient enough or too much?
Does more than that cause unwanted effects? This information would benefit this group
specifically performance-wise, as well as financially. Also, a study with a much larger pool of
subjects may increase power so, that determinations can be made with confidence. Afterwards if
indeed a significant effect is found, this would be of utmost importance to not only athletes but
fit individuals supplementing their diet as well.
Finally, it may be of interest to investigate if the supplementation of these antioxidants is
causing a proliferation of ROS themselves during moderate to high intensity exercise, when
taken in excess of the RDA. We know that vitamin E and vitamin C must be regenerated after
they neutralize any ROS. If they are not regenerated for some reason, might they be contributing
towards muscular fatigue? This would be an interesting finding if indeed this were the case.
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Appendix A: Food Diary Questionnaire
Food Diary / Record Packet for Participants in the
Antioxidant / Fatigue Study
These are the forms needed to report food intake for three days as required of subjects
participating in the aforementioned study. Please follow strictly follow directions in order for
your data to be usable.
•
•

List all foods and beverages consumed at and between meals for the three days.
Don’t forget such items as gravy, jams, sauces, salad dressing, nuts, candy, margarine /
butter, milk on cereal, fruit, or social beverages
Record foods immediately after eating (don’t rely on your memory)
List separately the foods that make up one dietary item (i.e. for a sandwich list bun, type
and amount of meat, butter, mustard, mayonnaise, etc.)
Express amounts of meat in ounces or grams, fruits and vegetables in cups or number of
that particular item (i.e., one orange, one tomato, etc.)
Bread may be recorded as number of slices
Beverages should be recorded in ounces or cups
Include at least one day during the weekend, among the three days recorded

•
•
•
•
•
•

Example:

Meal
Breakfast

Time

Food

Description

Amount

8 am

corn flakes

1.5 cups

2% milk

2 cups

Snack

10 am

Banana

raw

one

Lunch

1 pm

pasta

cooked

1.5 cups

marinara sauce

cooked

1 cup

iced tea
chicken breast
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20 ounces
cooked

8 ounces

Day One

Meal

Time

Food

Description

Amount

Day Two

Meal

Time

Food

Description

Amount

Day Three

Meal

Time

Food

Description

Amount

Appendix B: Pilot Study Data and Power Analysis for Sample Size
Pre = Pre-supplementation
acute = One day of supplementation
25 days = Twenty fifth day of supplementation
Table B.1 Data Chart for collected results
State
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
untr
tr
tr
tr
tr
tr
tr
tr
tr
tr
tr
tr
tr
tr
tr
tr

Subject supp
1
1
1
2
2
2
3
3
3
4
4
4
5
5
5
6
6
6
7
7
7
8
8
8
9
9
9
10
10
10
11
11
11

plac
plac
plac
vit
vit
vit
vit
vit
vit
vit
vit
vit
vit
vit
vit
vit
vit
vit
plac
plac
plac
plac
plac
plac
plac
plac
plac
plac
plac
plac
vit
vit
vit

time
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days
pre
acute
25days

work
1163.8
1385.8
1314.7
328.9
326.1
396.7
735.4
884.3
1034.3
732.2
675.2
807.7
806.5
789.4
576.1
448.1
796.9
719.6
516.2
622.4
690.2
1513.3
1801.5
2080.4
1290.4
1545.6
1501.2
826.8
980.4
993.5
1378.6
1493.9
1212.9
83

tr
tr
tr
tr
tr
tr
tr
tr

12
12
12
13
13
13
14
14

vit
vit
vit
vit
vit
vit
vit
vit

pre
acute
25days
pre
acute
25days
pre
acute

1155.5
1154.8
1021.1
1418.2
1486.9
1316.3
1945
1939.1

Figure B.1 ANOVA Results

Type 3 Tests of Fixed Effects

Effect

Num
DF

Den
DF

F Value

status

1

12

3.09

Pr > F

0.1045

Supple

1

12

0.29

0.5974
0.0517
0.0128
0.9057
0.0931
0.1468

status*Supple

1

12

Day

2

status*Day
Supple*Day
status*Supple*Day

84

2

4.67
24

24

2

0.10

24
2

5.25

2.63
24

2.08

Least Squares Means

Effect
DF
t Value
status
12
12.02
status
12
5.05
status*Supple
6.73
<.0001
status*Supple
10.76
<.0001
status*Supple
3.62
0.0035
status*Supple
4.26
0.0011
Day
24
10.45
Day
24
10.64
Day
24
9.46
Supple*Day
24
6.45
Supple*Day
24
6.43
Supple*Day
204.03
24
Supple*Day
24
10.04
Supple*Day
110.50
24
Supple*Day
110.50
24

status
Pr > |t|

Supple

tr
<.0001
untr
0.0003
tr

plac

tr

vit

Day

1379.67

114.75

982.63

untr

plac

untr

vit

1196.82
1562.52

acute
<.0001

pre
plac

25days

plac

acute

12

145.15

1288.10

25days

194.74
177.78

12

355.55

677.16

<.0001

<.0001

Estimate

Standard
Error

12

159.01

1212.42

12

116.02

1233.88

116.02

1097.15

116.02

1315.51

204.03

<.0001
<.0001
5.39
<.0001
10.46
9.90

plac
pre
<.0001
vit
25days
vit

<.0001

acute

vit
pre
<.0001

85

1311.64

204.03

1100.24
1109.32
1156.13
1094.06

110.50

Differences of Least Squares Means

Standard
Effect
Estimate

status Supple Day
Error
DF t Value

_status

status
tr
397.04
226.04
12
1.76
status*Supple tr
plac
229.51
12
-1.59

_Supple

_Day

untr
tr

vit

-365.69

The Mixed Procedure
Differences of Least Squares Means

Standard
Effect
Estimate

status Supple Day
Error
DF t Value

status*Supple tr
91.2750
397.52
status*Supple tr
519.66
238.51
status*Supple tr
274.42
384.04
status*Supple tr
885.36
215.30
status*Supple untr
610.94
389.49
Day
21.4667
45.3770
Day
115.27
45.3770
Day
136.74
45.3770
Supple*Day

_status

plac
untr
12
-0.23
plac
untr
12
2.18
vit
untr
12
0.71
vit
untr
12
4.11
plac
untr
12
1.57
25days
24
-0.47
25days
24
2.54
acute
24
3.01
plac
25days
86

_Supple

_Day

plac

-

vit
plac
vit
vit
acute
pre
pre
plac

acute

-

3.8750
79.8014
Supple*Day
215.28
79.8014
Supple*Day
206.19
232.03
Supple*Day
159.38
232.03
Supple*Day
221.45
232.03
Supple*Day
211.40
79.8014
Supple*Day
202.31
232.03
Supple*Day
155.51
232.03
Supple*Day
217.58
232.03
Supple*Day
9.0858
232.03
Supple*Day
55.8942
232.03
Supple*Day
6.1775
232.03
Supple*Day
46.8083
43.2206
Supple*Day
15.2633
43.2206
Supple*Day
62.0717
43.2206

24

0.05
plac
25days
24
2.70
plac
25days
24
0.89
plac
25days
24
0.69
plac
25days
24
0.95
plac
acute
24
2.65
plac
acute
24
0.87
plac
acute
24
0.67
plac
acute
24
0.94
plac
pre
24
-0.04
plac
pre
24
-0.24
plac
pre
24
0.03
vit
25days
24
-1.08
vit
25days
24
0.35
vit
acute
24
1.44
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plac

pre

vit

25days

vit

acute

vit

pre

plac

pre

vit

25days

vit

acute

vit

pre

vit

25days

vit

acute

vit

pre

vit

acute

vit

pre

vit

pre

-

-

Differences of Least Squares Means

_Day

0.1045
0.1371

Effect
Pr > |t|

status

Supple

Day

_status

_Supple

status

tr

untr

status*Supple

tr

plac

tr

vit

status*Supple

tr

plac

untr

plac

status*Supple

tr

plac

untr

vit

status*Supple

tr

vit

untr

plac

status*Supple

tr

vit

untr

vit

status*Supple

untr

plac

untr

vit

0.8223
0.0500
0.4886
0.0014
0.1427
acute
pre
pre
acute

Day
Day
Day
Supple*Day
0.9617
Supple*Day

25days

0.6404

25days

0.0180
0.0060

acute
plac

25days

plac

plac

25days

plac
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pre
25days
acute
pre
pre
25days
acute
pre
25days
acute
pre
acute
pre
pre

0.0126
Supple*Day
0.3830
Supple*Day
0.4987
Supple*Day
0.3494
Supple*Day
0.0140
Supple*Day
0.3919
Supple*Day
0.5091
Supple*Day
0.3577
Supple*Day
0.9691
Supple*Day
0.8117
Supple*Day
0.9790
Supple*Day
0.2896
Supple*Day
0.7271
Supple*Day
0.1639

plac

25days

vit

plac

25days

vit

plac

25days

vit

plac

acute

plac

plac

acute

vit

plac

acute
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acute
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pre

vit
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pre

vit

plac

pre

vit

vit

25days

vit

vit

25days

vit

vit

acute

vit

Table B.2 Power Analysis for Sample Size
Subjects Per Group (2 groups)

Alpha

Power

12

0.10

0.74

14

0.10

0.80
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Figure B.2 SAS Code for Power Analysis
Data SizeFix;
*Base specification;
a=2;dfS=1;
b=3;dfT=2;
ab=6;dfST=2;
*Specifications for power loop;
*Change aS, aT, aST level to 0.1 for type I=0.1. Change n;
aS =.05; cS =.75; cSsq = cS**2; powS =0; endS =.70; r=2;
aT =.05; cT =.75; cTsq = cT**2; powT =0; endT =.70; n=12;
aST=.05; cST=.75; cSTsq=cST**2; powST=0; endST=.70; w=1;
*Power loop;
Do until (powS >= endS and powT >= endT and powST >= endST);
nObs = r*a*n*b*w; *Experiment size and error degrees of freedom;
dfE1 = dfS*(r-1) + r*a*(n-1);
dfE2 = dfT*(r-1) + dfT*dfE1 + r*a*n*b*(w-1);
nS = r*n*b*w; *nTildas for noncentrality parameters;
nT = r*a*n*w;
nST = r*n*w;
parmS = nS * cSsq /2; *Noncentrality parameters;
parmT = nT * cTsq /2;
parmST = nST *cSTsq /2;
fS = Finv(1-aS , dfS, dfE1, 0); *Critical F values;
fT = Finv(1-aT , dfT, dfE2, 0);
fST =Finv(1-aST, dfST, dfE2, 0);
powS = 1 - ProbF(fS, dfS, dfE1, parmS); *Power;
powT = 1 - ProbF(fT, dfT, dfE2, parmT);
powST = 1 - ProbF(fST, dfST, dfE2, parmST);
output;
r=r+1; *nTilda ratches;
*n=n+1;
*w=w+1;
End;
Proc Print; Var r n w dfE1 dfE2 powS powT powST nObs;
run; quit;
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Appendix C: ANOVA Statistics Dissertation Study
Table B.1 ANOVA table
Source

DF

SS

MS

F

Pr

train

1

1765764.150

1765764.150

3.62

0.07

supp

3

274571.469

91523.823

0.19

0.90

train X supp

3

180431.321

60143.774

0.12

0.95

error

32

15604409.30

487637.79

total

39

17922768.64

Table B.2 Bonferroni Pairwise Tests
supp
train
supp
train
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute pla
acute vit
acute vit
acute vit
acute vit
acute vit
acute vit
acute vit
acute vit
acute vit
chronic
chronic

t-value
trained acute pla untrained 0.48
trained acute vit trained _0.96
trained acute vit untrained 0.35
trained chronic trained _0.69
trained chronic untrained 0.28
trained chronic trained _0.78
trained chronic untrained 0.53
untrained acute vit trained _1.34
untrained acute vit untrained _0.12
untrained chronic trained _1.09
untrained chronic untrained _0.18
untrained chronic trained _1.18
untrained chronic untrained 0.05
trained acute vit untrained 1.21
trained chronic trained 0.27
trained chronic untrained 1.14
trained chronic trained 0.18
trained chronic untrained 1.39
untrained chronic trained _0.96
untrained chronic untrained _0.06
untrained chronic trained _1.05
untrained chronic untrained 0.16
trained chronic untrained 0.89
trained chronic trained _0.09
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Pr
0.6369
0.3425
0.7316
0.4945
0.7837
0.4395
0.6023
0.1902
0.9059
0.2818
0.8564
0.248
0.9641
0.236
0.7871
0.2633
0.8577
0.1747
0.3422
0.95
0.3033
0.8703
0.3775
0.9276

chronic
chronic
chronic
chronic

trained chronic
untrained chronic
untrained chronic
trained chronic

untrained 1.14
trained _0.98
untrained 0.23
untrained 1.23

0.2609
0.336
0.8212
0.229

Figure B.1 SAS Code for Power Analysis
/*Dissertation power analysis*/
data Power;
FSUPPSTATUS=Finv(0.90, 3, 32,0); PSUPPSTATUS=1ProbF(FSUPPSTATUS,3,32,-2.43);
FTRAINING=Finv(0.90, 1, 32, 0); PTRAINING=1ProbF(FTRAINING,1,32,2.62);
FSUbyTRAIN=Finv(0.90, 3, 32,0); PSUbyTRAIN=1ProbF(FSUbyTRAIN,3,32,-2.64);
proc print NoObs;
run;
quit;
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Appendix D: Consent Form
1. Study Title:
The effect of an antioxidant supplementation protocol upon muscular fatigue in trained and untrained
subjects during repetitive arm curl exercise
2. Performance Sites:
Exercise testing will be done in room B13 of the Gym Aromory
3. Contacts:
Dr. Arnold Nelson
Ivan K Guillory
112 Long Field House, LSU
1476 Lake Calais Ct, Apt D
Baton Rouge, LA 70803
Baton Rouge, LA 70808
phone (work) (225) 578-2036 (7 am - 4 pm) phone (225) 757-9527
Home (225) 766-4621 (5 pm - 10 pm)
e-mail: anelso@lsu.edu
e-mail: iguillo@attglobal.net
4. Purpose of the Study:
The purpose of this study is to determine whether or not supplementing with vitamins A,
C, and E will attenuate the fatigue seen performing a prescribed arm curl exercise protocol.
5. Subjects:
A. Inclusion Criteria
Forty healthy subjects are needed. Both males and females are invited to participate.
Participation is voluntary. Two types of subjects are needed, trained and untrained group. Untrained is
defined as individuals who do not currently participate in strength building exercise. Trained subjects
are those currently undergoing a strength building program with a frequency of no less than three days
per week. All potential participants must complete the Physical Activity Readiness Questionnaire
(PAR-Q) before inclusion into the study. Only those individuals who answer “no” to all questions will
be used as research participants.
B. Exclusion Criteria
Any person on any type of medication, or currently supplementing with any antioxidant
vitamins. Also anyone who knows that they are hypersensitive to vitamins A, C, or E.
C. Maximum number of subjects: (including controls)
40
6.
Study Procedures:
Supplementation Protocol
Before the supplementation protocol can begin each subject will compile a seven day food diary
to assess antioxidant vitamin status. Each diary will be assessed for RDA levels of the selected
vitamins, and to what extent that those levels have been met or exceeded. Subjects will ingest an
antioxidant tablet containing 25,000 international units of beta carotene, 400 international units of
vitamin E, and 500 milligrams of vitamin C. or a placebo (sugar pill). Subjects will supplement on an
antioxidant vitamin tablet containing the aforementioned substances, for a total of fifteen days. After a
thirty day washout period, they will be ingesting a placebo for fifteen days. Beta carotene is an
antioxidant that is a precursor to vitamin A, often called pro-vitamin A. Vitamin E is used in the body
to protect cell membranes from oxidation. Vitamin C, among its other functions, acts as an antioxidant
and helps to regenerate vitamin E. The dosages that we are using are considered safe and are even
within the guidelines established by the United States Olympic Sports Medicine Committee (Table 1)
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Table 1.
Nutrient
Beta Carotene
Vitamin C
Vitamin E

Supplement Range
5,000 – 33,000 IU
250 – 1,000 mg
100 – 400 IU

Invasive Procedures (OPTIONAL)
To have a better understanding of the residual amount in the blood of the above vitamins, blood
will be taken at two different time during the study. The first blood sample will be taken at the end of
the washout period and before the second supplementation period. The second blood sample will be
taken at the end of the study. All blood draws will be performed at the cmedical clinic of the
Pennington Biomedical Research Center. A total of 5 ml of blood will be taken by a certified
phlebotomist at each of the two times mentioned above. The blood samples will be analyzed for
vitamin concentration by the clinical chemistry specialists at the Pennington Biomedical Research
Center. PLEASE NOTE THAT THESE BLOOD DRAWS ARE OPTIONAL. ANYONE WHO DOES
NOT DESIRE TO HAVE THEIR BLOOD SAMPLED WILL NOT BE ASKED TO DO SO NOR BE
ASKED TO TERMINATE THEIR PARTICIPATION IN THE STUDY.
Testing Protocol
The testing procedure will consist of an initial assessment using a Biodex dynamometer., and
subsequent tests at day one and day fifteen of each supplementation period. The exercise protocol will
consist of six sets of arm curl exercises, using the left arm, with a one minute rest between each set.
Twenty repetitions will constitute one full set. The speed of movement will be set at 60 degrees per
second for flexion and, 400 degrees per second for extension (this speed will allow subjects to relax on
the eccentric phase). The subjects will be instructed to give all out effort for each set. Subsequently
total work (force multiplied by distance) for each set will be measured by the dynamometer in order to
give a measure of the rate of fatigue.
Time line for Experiment
Days 1-7

Subjects record diet for seven days. At the end
of the recording period, subjects will have the
initial assessment on the dynamometer.

Day 14 and 15

Subjects begin the supplementation period.
On the second day, they will again be
assessed on the dynamometer.

Day 28

Subjects continue supplementation, and on the
fifteenth day are assessed on the dynamometer

Day 29 - 58

Subjects undergo washout period

Day 58

Volunteers will report to the Pennington
Clinic for a blood draw.
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Day 59 and 60

Subjects begin the second supplementation
period. On the second day, they will again be
assessed on the dynamometer.

Day 73

On the last day of supplementation, subjects
will again be assessed on the dynamometer

Day 74

Volunteers will report to the Pennington
Clinic for a blood draw.

7.

Benefits:
Subjects may benefit from the study from learning their status for these selected antioxidants
after completing the food diary. They may also discover a beneficial effect upon muscular fatigue
individually, after supplementing with the antioxidants. Also, general knowledge about the practice of
supplementing with vitamins and their affect upon muscle fatigue will be learned and added to the
current body of literature on the subject.
8.
Risks/Discomforts:
There are small inherent risks involved with taking place in this study. It’s possible that the
subject could strain a muscle, experience light headedness, or nausea as they will be required to give
maximal effort. There is no report risk for the supplementing these vitamins at the proposed dosage. At
this time, however, the researcher will read to you the manufacturer’s warning label
Additional risks may be encountered by those individuals who volunteer for the two blood
samples. A person having a blood sample runs the risk of pain at the site of the blood draw, bruising at
the same site, and the development of blood clots (hematoma) at the blood draw site. The chances of
either bruising and developing blood clots are greatly reduced if the person follows the instructions of
the phlebotomist.
9.
Measures taken to reduce risk
All subjects will do a warm-up routine before exercising, this will help reduce the risk in the
trained subjects. Warm-up will reduce exercise risk in untrained individuals very little. The only way to
them to reduce the risks of the exercise is not to perform the exercise.
To reduce the risks associated with a blood drawn, only trained certified personnel in the
employment of the Pennington Center will be allowed to take the blood samples.
10.
Right to Refuse:
ll volunteers may terminate their participation at anytime and without warning. The individual
just needs to stop the activity and leave the weight room. No attempt will be made by the research
personnel to stop the volunteer. In fact, the research personal will do all in their power to help the
volunteer leave at any time.
11.
Privacy:
The results of this study will be tabulated in an anonymous manner. This means that the
researchers will be unable to give you your results, as they will not be able to identify yours from the
rest.
12.
Financial Information:
This project will not effect the participants finances in either a positive or a negative manner.
13.
Withdrawal:
Withdrawal form the study can occur at anytime without any fear of punitive action.
14.
Removal:
If the researcher has trouble scheduling the volunteer to come to the test, or if it is discovered
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that the subject is not taken the pills in the prescribed manner, that volunteer will be dropped from the
list of volunteers. The volunteer has the right to change their minds about participation at anytime
before or during the study.
----------------------------------------------------------------------------------

Part 5: Signatures:
1.

‘The study has been discussed with me and all my questions have been answered. I may direct
additional questions regarding study specifics to the investigators. If I have questions about
subjects' rights or other concerns, I can contact Robert C. Mathews, Chairman, LSU
Institutional Review Board, (225)578_8692. I agree to participate in the study described above
and acknowledge the researchers’ obligation to provide me with a copy of this consent form if
signed by me.’
Subject Signature ___________

Date ________________________________

2.
‘The study subject has indicated to me that he/she is unable to read. I certify that I have
read this consent form to the subject and explained that by completing the signature line above,
the subject has agreed to participate.’
Signature of Reader _______________ Date ________________________________
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Appendix E:Power and Statistical Significance
When conducting statistical tests to describe the characteristics of a group of data there
are certain distinct measures that come in to play. Those measures include, probability (alpha and
beta), effect size, and power.
Probability is defined as the chance that a certain event will occur. An example used
frequently is in the case of flipping a coin. One would expect that if a coin is tossed 50 times it
would come up heads 25 times and tails 25 times or 50% (0.50). This may or may not occur,
however if this test were repeated a number of times you would expect the frequency of scores to
be closely huddled around 50% (Thomas and Nelson, 2001). In statistics probability statements
are used to describe confidence in the findings of the research. In research, probability is used to
protect against making two types of error - Type I and Type II. Type I error occurs when the null
hypothesis is rejected although it is true. Type II error is to fail to reject the null hypothesis when
it is false.
The probability statistic used to guard against a Type I error is called alpha. The
statement used to describe the confidence placed in statistical findings is called a probability
statement (Thomas and Nelson, 2001; Freund and Wilson, 1997). A typical probability statement
may appear as p<0.01, meaning the difference detected would be expected less than 1% of the
time as a result of chance. Within the science community the alpha level is almost always set at
either 0.01 or 0.05. As mentioned previously this is done to protect against a Type I error. For
example, in an experiment in which a supplement is given, Type I error protects against
detecting a difference when the supplementation really had no effect. The higher the alpha level
the more opportunity that is given to show any difference but, conversely the chance of Type I
error increases. There is no official reasoning as to why 0.05 and 0.01 have been accepted by the
97

scientific community as the “gold standard” for alpha level. The decision comes down to which
type of error is more acceptable to the researcher, Type I or Type II. In a study in which a drug is
being tested, but has never shown to be harmful, it might be acceptable to set alpha at 0.10 to
give that drug every opportunity to have an effect. In a paper by Franks and Huck (1987) it is
posed that there are indeed instances when a higher significance level may be warranted. Sample
size can be determined via a formula that takes into account, among other things, alpha level.
However, in many instances in exercise and physical activity research, there are times when
there is only a limited sample available. In addition, there are factors that are beyond control
such as costs of the experiment, subject dropouts and / or availability, and incomplete data
(Franks and Huck, 1987). In this case setting alpha at 0.10 or another value may be worth the
added risk of Type I error when weighted against the consequence of committing a Type II error.
Finally, in the example of the drug testing, in an exploratory study it may actually be more costly
to experience a Type II error, that is, the drug actually has an effect, but the researcher accepts
the null hypothesis of no effect.
Beta is the test statistic used to specify the probability of making a Type II error. Again,
the Type II error is a failure to reject the null hypothesis when it is false. If sample size stays the
same beta will grow smaller as alpha is increased (Freund and Wilson, 1997). Conversely, power
is the probability of rejecting the null hypothesis when it is false (Thomas and Nelson, 2001).
The subject of power will be covered later in this paper.
Effect size (ES), or meaningfulness of differences, has been defined as “the magnitude of
the real effect to be detected” (Thomas, Lochbaum, Landers, and He, 1997). Simply put it is the
meaningfulness of difference between two means (Thomas and Nelson, 2001). It is calculated as:
(Me - Mc)/Sc
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This calculation is the mean of the experimental group minus the mean of the control group with
the difference divided by the standard deviation of the control group (Thomas, Lochbaum,
Landers, and He, 1997). If there is no control group, a pooled standard deviation between the two
group means should be used (Thomas and Nelson, 2001; Hedges and Olkin, 1985). Guidelines
for behavioral research were suggested by Cohen (1969) and within those guidelines he
suggested an ES of 0.2 as small; 0.5 as moderate; and 0.8 as large differences. Thomas, Salazar,
and Landers (1991) posed the idea that all authors of research should report ES in their analysis.
One reason for this is the chance that small differences may be declared significant because of a
combination of a large sample and small variance, or a large variance and small sample size. In a
paper by Cohen (1990) it is argued that the main purpose of research should be to measure effect
size rather than p values. The logic behind this is that a single study based upon a decision at the
p<0.05 level is not likely to have an impact upon theory, but that reporting effect size allows
there to be a standard of comparison between past, present, and future research. Clearly this
would help to guide research on the selected topic for the future. As will be discussed later, ES,
alpha level, and sample size are instrumental in helping to determine power for a given study. If
the sample size is low, as is the case many times in physical education research, a higher than
normal alpha level, or large ES, or both may have to be adopted to maintain a certain desired
level of power (Thomas and Nelson, 2001)
Statistical power has been described as “the probability of not making a Type II error”
(Norton and Strube, 2001). In other words, it is the probability of making a correct
determination. Consequently, if beta is representative of the probability of making a Type II
error, then the probability of not making a Type II error is mathematically represented as 1 beta. Therefore,

1 - beta may be labeled as the mathematical expression of power. The
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greater the power, the higher the chance of detecting a real difference in the analysis. The four
main components that affect power are alpha level, group means, sample size and variability
among subjects (Norton and Strube, 2001). Alpha level affects power indirectly, through its
influence upon Type I and Type II error. When alpha is increased, the chance of making a Type I
error is increased, while at the same time the chance of making a Type II error is decreased
because beta is decreased. A subsequent decrease in beta results in an increase in power, because
of the mathematical relationship of beta and power (power = 1 - beta). Group means have an
influence on power through their differences between the group means for the null hypothesis
and experimental group means. Logic tells us that the larger the difference between group means,
the easier the detection of any differences. In other words, power increases when the difference
between the two means becomes larger. Subject variability may also have an effect on power. In
a graphic comparison between two distribution of scores, one distribution curve may have the
same mean of another distribution curve. However, one curve may be wider than the other
because of greater variability among the scores within its distribution. If these two curves
overlap and one represents the distribution of the null hypothesis and the other the research
hypothesis, the greater the overlap in the scores between the two distributions, the larger the beta
and therefore a subsequent decrease in power (Norton, and Strube, 2001). Finally, the sample
size may also influence power. Basically, as sample size is increased power is increased.
Increasing sample size reduces the variability of the sample group means (Thomas and Nelson,
2001; Norton and Strube, 2001).
Via the use of a power analysis it is possible to determine the number of subjects or
observations necessary when planning a study. Using ES, alpha level and power it is possible to
calculate a value for sample size. As stated previously, ES may be determined by a previous pilot
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study, or it may be determined from the means of a number of related studies (Thomas et al,
1997). It is suggested that the ratio of alpha level to beta level should be 1 to 4 (Thomas and
Nelson, 2001). For example, if an alpha of 0.05 was selected then beta should be set at 0.20 and,
likewise when alpha is set at 0.10 beta should be set at 0.40 ( power = 0.60). Again, the
researcher must determine what type of error is most important to avoid within the planned
study. Upon obtaining the ES, alpha level and effect size, the sample size is determined via effect
size curves (Thomas and Nelson, 2001; Thomas et al, 1997), using simple formulas (Cohen and
Cohen, 1983), or relying upon statistical software such as SAS or SPSS. As noted earlier, sample
size has a large influence upon power. For example, for an ES = 0.5 and an alpha of 0.05, a
sample size of 10 results in a power = 0.20 and a sample size of 20 would result in power = 0.30
(Thomas and Nelson, 2001).
Power analysis may also be used after the completion of a study. After the study is
completed, a power analysis can determine if the level of power is adequate to justify any kind of
conclusion (Norton and Strube, 2001). For instance, after the power analysis is finished if the
power level is determined to be lower than the desired level, then a decision must be made by the
researcher to either not accept the result due to inadequate power or risk the increased chance of
a Type II error. This kind of problem may occur if there are a significant amount of subjects that
drop out or discontinue participation in the study. Again, power analysis is usually determined
using statistical software such as SPSS or SAS.
It is well known that statistical significance is representative of a test of the difference
between experimental groups (Thomas et al, 1997). Either a difference between group means is
significant at the specified alpha level or it is not significant. However, there is a distinction
between the significance of the differences and the meaningfulness of the differences. By
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definition meaningfulness is “the importance or practical significance of an effect or
relationship” (Thomas and Nelson, 2001). It is plausible then, for a study to have outcomes that
are not statistically significant but, because of the effect size(s), may have a meaningful outcome
when compared to effect sizes within the existing literature (Thomas et al, 1997; Norton and
Strube, 2001; Thomas and Nelson, 2001). Effect size makes it possible to compare results across
many different studies, that address a similar question, because of the way it standardizes the
effect magnitude to a value that can be compared, although scaling properties of the
measurements of each study are different (Norton and Strube, 2001). So, regardless of the
statistical significance at a given alpha level for a given study, studies still can be compared and
may still contribute to the existing knowledge in regards to the particular question being
addressed.
As an example of determining sample size, we could consider the improvement of world
class sprinters attempting to improve their time in the 400-meter run. If we wanted to see if a
certain supplement, in this case creatine phosphate, improved 400-meter sprint times we would
first conduct a pilot study in which one group (experimental group) of sprinters ingested the
creatine supplement for a given amount of time, and the other group (control group) ingested a
placebo. There are 10 athletes in each group. Each sprinter would be timed in the 400 meters
before the supplementation began, and at the end of the supplementation period. Afterwards,
their improvement in hundredths of seconds would be recorded. In world class sprinters we
would not expect a large improvement. Improvements in that event are sometimes measured in
tenths or hundredths of seconds. However, that small improvement may well be the difference
between an Olympic gold medal and fourth place. So, following a pilot study we calculated the
mean of the difference in pre- and post-supplementation times for the five athletes in the
102

experimental group and the control group. The experimental group received five grams of
creatine per day for thirty days and the control group received a placebo for the same amount of
time. Afterwards, their improvements were recorded. The mean improvement for the
experimental group was 0.1 seconds and the control group was 0.05 seconds. The standard
deviation of the control group is equal to 0.03. So, with this information we can calculate a
sample size needed for a larger study. We use the same formula mentioned earlier to first find the
effect size:
(Me - Mc)/Sc
(0.10 - 0.05)/0.03 = 1.6
With an ES = 1.6, we will assume a desired power as 0.8 and an alpha level of 0.05. Using
Sigma Stat statistical software package to calculate a sample size for a one way ANOVA, we
would find that we need two groups of seven subjects to detect a meaningful difference between
the two groups, supplemented and placebo.
Now that we have the minimum sample size we can collect the data from the main study.
Since we need a minimum of 7 subjects per group we recruit twenty subjects. Then we set up a
similar protocol to the pilot study. Ten subjects will ingest the creatine for thirty days and the
other ten will ingest the placebo. Four hundred meter sprint times are tested before and
immediately after supplementation. In the experimental group the mean of the differences
between pre and post supplementation is equal to 0.33, and for the placebo group 0.06.
Following a one way ANOVA it is found that there is a significant difference between the
experimental group and the placebo group such that p<0.001. Following the test, we determine
the power to be equal to 1.0 taking into account the difference of the means (0.27) and a p=.001.
So, following this test we would conclude that supplementation with creatine is beneficial to
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world class 400-meter sprinters in reducing their 400-meter sprint times. However, if the case
had been that the p=0.07 and the power were .75 then the researcher would have to make the
decision as to which error is most acceptable. With an alpha level at 0.07 the chances of rejecting
the null hypothesis when it is true is 7 times out of 100. Conversely, the power is 0.75 which is
not 0.8, but very close. In a study such as the aforementioned, the researcher is using a
supplement (creatine) that has not been shown to be harmful with only 30 days of
supplementation. So, the decision may be made to reject the null (of no benefit) to give the
supplement every opportunity to work. This may not be a bad decision with the power being
0.75. A power at that level would indicate that there is a 25% chance of making a Type II error.
But, again, as the null is that there is no benefit from taking creatine, making a Type II error
would not be harmful to the participants and may be worth the risk to the investigator. This
would have to be the options weighed before a decision is made whether to accept or reject the
null hypothesis.
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Appendix F: Obtaining and Motivating Subjects
When conducting a study that entails subjects having to take a drug / supplement and
then to perform an exercise protocol at specified intervals throughout a calendar year, there are
inherently some issues that rise up that affect subject compliance and motivation.
One concern that has been apparent is the subjects initial apprehension towards the
supplement. Since, most lay people are not educated about nutrition or experimental research
some questions arise as to the harmful or possible side effects of the supplement. At the
beginning of any study involving the supplementation of a nutritional aid, the researcher should
explain in detail the nature of the action that the supplement has within the body. This should be
done through a group question and answer period and in a detailed written description of the
supplement and its action / side effects.
Obtaining subjects for physical activity research can be difficult if there is no incentive
for subjects to participate. For example, Cohen, Chelland, Ball, and LeMura (2002) used
monetary reward to subjects participating in a physical activity study involving riding a cycle
ergometer. They found that the monetary rewards motivated the subjects to ride for a longer time
on the cycles than when no money was awarded. For many researchers the awarding of a
monetary sum to all subjects is just not financially feasible. However, if they were to make it into
a contest or lottery situation in which the subject with the best effort, or best attendance, won a
reward, this would serve to be a motivating factor because it would appeal to the subjects
competitiveness. Another example of a reward system would involve soliciting college students
to participate, whereupon the researcher negotiates rewards for their participation via the college
/ university or individual professors, preferably in courses related to physical activity.
It may be difficult to keep subjects motivated if a study is long or involved. There are
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also factors such as boredom, activity preferences, and even group cohesion that may affect
subjects lack of compliance during a study. Perhaps having periodical meetings of the subjects
would help to motivate individuals. These meetings could serve as question and answer, as well
as motivational periods. When the subjects see that they are a part of a larger group, this may
help to motivate them to continue in the study (Spink and Carron, 1992). Encouragement and
accountability to the group may serve as a motivating factor for individuals who feel isolated and
are not sure that their participation makes any kind of difference. If subjects do not enjoy the
mode of exercise being used in a study, then the likelihood of them staying motivated and
participating in the study is diminished. When individuals are enjoying an activity they get
positive feedback from that participation (ACSM, 1993, pp. 447). However, if they do not then
they experience the opposite feelings (Stutts, 2001).
If time permits researchers may be able to use advance advertisement to recruit
volunteers. Yancy et al (2001) used what is referred to as passive and active recruitment. Passive
recruitment involved placing ads in the local paper or radio station (public service
announcements), and also social networking. They also posted flyers at community sites and
organizations such as churches, grocery stores, and neighborhood centers. This strategy could
easily be adopted to a university setting by utilizing the school newspaper, radio station, student
health center, recreational center, or personal friendships / relationships. They also used a
method called active recruitment in which potential subjects were contacted directly. The
methods used included mass mailings, presentations at selected churches, meetings of
community organizations, and community health fairs. Again, in the case of recruiting from a
university population these methods may be adapted to that particular community. Investigators
could send out detailed letters to professors and leaders of student organizations to define what
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the study is investigating, in hopes that these leaders will motivate their students or members to
participate in the study. Likewise the investigators could make presentations at the meetings of
said student organizations to introduce the students to the type of work being performed and how
the students can help, and possibly even benefit from participation. During these presentations
they can appeal to the audience’s desire to help others, if the study has some medical or health
ramifications. As most universities now have student health fairs during the school year, these
are prime locations to introduce the work that the group is doing, and to request volunteers for
the upcoming study. To ensure the target population are being admitted to the study, researchers
could also use a screening questionnaire. In the case of a study needing subjects from a certain
age range, and / or fitness level, a questionnaire could be tailored to include domains such as
smoking status, disease status, age range, etc. (Yancy et al, 2001). These methods have been
used by many researchers to transcend the obstacles to recruiting subjects for physical activity
research.
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Appendix G: Journal Article
Introduction
The recent interest in antioxidants and free radicals has prompted an increase in the
supplementation of these substances by many in the general public. Athletes believe that
supplementing their diet with antioxidants helps to maintain their optimum fitness level. To this
end vitamin manufacturers market antioxidants to athletes, professional and amateur alike, as an
ergogenic aid counteracting the effect of oxidative stress during exercise (Urso and Clarkson,
2003; Applegate, 1999; Juhn, 2003; American Dietetic Association [ADA], 2000). It is well
accepted that exercise causes an increase in the production of free radicals and other reactive
oxygen species (ROS) (Powers and Hamilton, 1999). Among these ROS are O2- (superoxide
radical), H2O2 (hydrogen peroxide), and OH (hydroxy free radicals). A proliferation of these free
radicals can cause a decrease in the function of affected cells and can result in a decreased ability
of muscles to maintain work. Some may believe that the ingestion of antioxidants will help to
stave off this proliferation of free radicals during exercise and thus provide a beneficial effect.
The human body has adequate antioxidant defenses under normal physiological
conditions. These defenses include enzymatic and nonenzymatic antioxidants within the interior
and exterior of cells. The non-enzymatic include antioxidant vitamins, uric acid, glutathione,
alpha lipoic acid, bilirubin, and ubiquinones (Powers and Hamilton, 1999). Enzymatic
antioxidants are located mainly within the mitochondria and cytosol, and include superoxide
dismutase, glutathione peroxidase, and catalase
Vitamin E, vitamin C, and beta-carotene are three antioxidants that have garnered the
most attention from those who wish to supplement their diets with exogenous nutrients. Vitamin
E works to protect cell membranes by breaking the chain reactions that attack the lipid portions
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of those membranes. Vitamin C is an antioxidant that works in conjunction with vitamin E and is
located in the cytosol of cells. It helps to regenerate vitamin E that has been used to fight the
lipid peroxidation occurring within cell membranes. Beta Carotene is a form of vitamin A called
pro-vitamin A. It can be converted into vitamin A as needed by the body, and much of it is
located between the lipid bilayers of cell membranes. In this position, it also acts as an
antioxidant protecting cell membranes.
During strenuous exercise, there is an increase in oxygen uptake by working muscles. As
work intensifies, oxygen uptake increases. This increase in oxygen uptake results in an increase
in ROS that may result in the fatiguing of working muscles (Powers and Hamilton, 1999; Davies,
Quintanilha, Brooks, and Packer, 1982). There is evidence that suggests supplementing the diet
with antioxidant nutrients may help to stave off the effects of an increase in ROS (Novelli,
Bracciotti, and Falsini, 1990; LeBlanc, 1998; Lang, Gohil, and Packer, 1986; Samanta and
Biswas, 1985; Brown et al, 1997; Allesio et al, 1997 ). However, most studies have investigated
the effect of these antioxidants upon continuous endurance exercise, and have not used an
intermittent work protocol, nor the three antioxidants in combination, being utilized here.
In this study we have investigated the effect that an acute and a chronic supplementation
regimen, with an antioxidant mixture of beta-carotene, vitamin C, and vitamin E, has upon work
capacity during an intermittent work protocol in trained and untrained subjects. Additionally, we
will observe if there is any significant interaction between the trained and untrained subjects
work values from the acute placebo phase through the chronic vitamin phase.

Methods
Subjects. Thirty-six male and female volunteers were recruited, aged 19-34 years, who,
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after completing an informed consent form, were deemed healthy and on no medications.
Subjects were classified as either trained (n=24) or untrained (n=12). Trained were those who
engage in strength training on a regular basis (at least one day per week) for a period of at least
one year. Untrained were those who do not participate in any strength training. All subjects were
required to be nonsmokers and to not be taking any vitamin supplements at the time of the study.
Dietary Assessment. A subgroup of ten subjects completed a 3-day food diary prior to
supplementation to assess current intake for the antioxidants being ingested. The information
therein was analyzed using the software, Food Processor for Windows (version 7.30) by ESHA
Research.
Experimental Design. Subjects ingested either one antioxidant capsule containing (25,000
IU of beta-carotene, 400 IU of vitamin E, and 500 mg of vitamin C), or a disguised placebo, per
day for a period of 25 days. The capsules were administered in a double blind fashion so as to
remove bias from the investigation. The antioxidant capsules are produced by Vitamin World,
Inc. and, are manufactured to the standards of the United States Pharmacopeia / National
Formulary requirements.
The testing procedure consisted of an initial practice session using the Biodex
dynamometer (one week prior to supplementation), and subsequent tests at day one and day
twenty-eight of each supplementation period. Each subject was tested within a 12 hour range of
the time of the original test, for each of the subsequent tests. For example, if the original test was
at noon, then the tests at one day and twenty-eight days would be between six a.m. and six p.m.
on those days. The exercise protocol consisted of five sets of arm curl exercises, using the nondominant arm, with a 1 minute rest between each set. Twenty repetitions constituted one full set.
The speed of movement was set at 60 degrees per second for flexion and, a maximum of 400
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degrees per second for extension (this speed allowed subjects to relax on the eccentric phase).
The subjects were instructed to give all out effort for each set. Subsequently, total work (force
multiplied by distance) for each set was measured by the dynamometer in order to give a
measure of the rate of fatigue. The sum of the total work of the last two sets was used in
determining fatigue.
Statistical Analysis. Following data collection all results will be analyzed and compared
for significance. A two-way (treatment X day) ANOVA with an alpha level of p<0.10, was used
to compare within and between group differences.
Results
Dietary Assessment. Subjects completed the 3-day food diary to assess current intake for
the supplemented antioxidants. The information therein was analyzed using the software, Food
Processor for Windows (version 7.30) by ESHA Research, as described earlier. The results for
each subject are listed in table 1. The means for each antioxidant are listed for each subject for
the three day period. This allowed estimation of the extent to which the RDA for the selected
antioxidants are being met or exceeded, in the regular diet. Mean group values for beta-carotene,
vitamin C, and vitamin E respectively, were equal to 1791.415 mcg (St err = 738.819), 175.645
mg (St err = 94.007), and 6.678 mg (St err = 1.752).

Table 1 Antioxidant Vitamin Measures From Food Diary Data
Subjects

Beta-car. (mcg)

Vitamin C (mg)

Vitamin E (mg)

1

811.12

98.42

2.68

2

498.62

87.89

5.30

3

3122.46

1017.19

14.56

4

1388.48

63.19

4.21
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5

330.18

99.37

3.98

6

9.38

31.12

4.96

7

574.32

107.25

8.50

8

223.93

102.29

1.58

9

7494.26

31.42

2.72

10

3461.40

118.31

18.29

Work Measures. Following the intermittent work protocol, work measures for each
subject at each supplementation period were recorded (Table 2). The protocol was conducted on
the Biodex dynamometer in the kinesiology lab at Louisiana State University. Mean values for
each phase are reported in Table 3.
Table 2. Work Measures for Each Subject
status

acute plac
chronic plac

untrained
untrained
untrained
untrained
untrained
untrained
untrained
untrained
trained
trained
trained
trained
trained
trained
trained
trained
trained
trained
trained

622.4
699.2
1213.1
1801.5
1545.6
980.4
1322.5
1234.1

acute vit

chronic vit

326.1
884.3
675.2
789.4
460.9
1194.7
806.1
796.9

396.7
1034.3
807.7
676.1
599.9
1116.1
1219.6
719.6

1493.9
1154.8
1486.9

1212.9
1021.1
1316.3

690.2
1039.6
1628.4
2080.4
1501.2
993.5
1413.3
1028.9
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trained
trained
trained
trained
trained
trained
trained
trained
trained
trained
trained
trained
trained
untrained
untrained
untrained
untrained

1939.1
1753.4
1879.2
754.7
1168.4
1288.4
915.8
923.5
1186.1
688.4
1490.1
1484.9
1217.4
673.8
1385.8
678
209.6

1688.1
1740.1
1972.1
583.6
1022.2
1072.7
679.4
969.4
1321.7
731.2
1414.9
2228.6
1058.4

754.1
1314.7
530.7
411.5

Table 3 Work Mean Values
Status

Supp. Phase

Mean Work

trained

acute placebo

1178.29

trained

chronic placebo

1321.14

trained

acute vitamin

1142.12

trained

chronic vitamin

1072.59

untrained

acute placebo

823.60

untrained

chronic placebo

827.70

untrained

acute vitamin

1048.93

untrained

chronic vitamin

1195.53

A two way ANOVA was used to detect any differences in the data. Although upon viewing the
data graphically (Figures 1 and 2) there appears to be an influence upon the untrained subjects
supplementing with the antioxidant, the data show otherwise. For the main effects
supplementation status, and training, there were p values of 0.88 and 0.09 respectively. For the
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interaction of supplementation status and training, p value was equal to 0.25. There was a small
effect size of 0.26 for the effect of training. Power for supplement phase, training, and their
interaction was <0.10, 0.29, and <0.10 respectively.
Discussion
Dietary Assessment. Vitamins C and E, and beta-carotene intakes were estimated using
3-day food diaries. Each subject was given a diary to completely record everything that was
eaten during a three day period. As invasive measures of these two of the nutrients were not
investigated, it was determined that recording daily intake of these nutrients would provide the
best estimate of tissue levels for this particular group. Assessment of the subjects’ status in
regards to the antioxidants studied, was necessary to ensure that there were none of them starting
from a point of deficiency, prior to the start of the experiment.
Currently there is no RDA for beta-carotene in humans. However, the RDA for vitamin A
is 0.8 - 1.0 retinol equivalents (RE) (Groff et al, 1995). Beta-carotene is a precursor to vitamin A,
and is often called pro-vitamin A.. The body cleaves stored beta carotene as needed to maintain
serum vitamin A levels within the body.
There appears to be no serious side effects when ingesting beta-carotene in excess of the
RDA for vitamin A because it is not converted to vitamin A until the body needs it.
Following diet analysis for each subject, the software displayed information for each
vitamin and mineral with an RDA and also other nutrients, such as beta-carotene, that do not
currently have an RDA. The Food Processor for Windows software reported total vitamin A /
provitamin A in the diet. It also gave beta-carotene content as a separate measure from total
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Figure 1 Trained Subjects Work Graph

Trained Subjects

2000

1000
500
0
tra acut pla

tra chron pla

tra acut vit

tra chron vit

Supplementation Status
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untr chron vit

vitamin A content. Our subjects mean intake for beta-carotene during the three days of listing
food intake was 1791.415 mcg (Std = 2336.35). Six micrograms of beta-carotene is equal to one
RE. Again, this measure was just a part of the total vitamin A intake, but it does illustrate the
extent to which the subjects were meeting the RDA for vitamin A. On average the subjects
ingested 298.57 RE per day for the three day period. This far exceeds the RDA for vitamin A and
ensures, barring any malabsorptive disorders (pancreatic, liver, or gall bladder diseases), that the
subject pool was not vitamin A deficient prior to the supplementation regimen (Beta-carotene
ingestion for each subject is listed in table 1).
The RDA for vitamin E is 8 mg and 10 mg tocopherol equivalents (TE) per day, for
women and men respectively. The normal intake for vitamin E in American diets is 4 mg TE to
22 mg TE/day for individuals not supplementing their diet with exogenous vitamin E (Di Mascio
et al, 1991). Again, vitamin E requirements increase as the intake of PUFA increases or
decreases. Because of this dependency upon PUFA content, determining a precise requirement
for vitamin E has been difficult. However, because most foods high in PUFA are also high in
vitamin E, there is not much fear of deficiency. In fact, vitamin E deficiency in humans is very
rare. As in the case with beta-carotene, deficiency in adults is only seen in those suffering from
malabsorption diseases, especially those that affect the absorption of fats.
The diet analysis determined that the mean intake for vitamin E for each subject for the
three day period was 6.678 mg TE/day (Std dev=5.54). This is just below the RDA for vitamin E
but is well within the normal intake for those consuming a typical American diet (Di Mascio et
al, 1991). This also falls between the range stated by Guthrie and Picciano (1995), between 5 and
20 mg TE/day, that would be considered safe depending upon PUFA intake. Considering the
rarity of vitamin E deficiency, and the fact that our subjects intake of vitamin E falls between the
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range for normal intake, it is highly unlikely that these subjects were vitamin E deficient before
beginning the supplementation regimen.
The RDA for vitamin C is 60 mg/day for adult men and women. This amount was chosen
based upon the amount required to maintain a body pool of 1500 mg (the amount of vitamin C
that can be held within the body without excretion via the kidneys). The subjects’ food diaries
showed that the mean intake for each subject per day was 175.645 mg of vitamin C per day (Std
dev=297.28). This number exceeds the amount in the RDA, but is far below the amount
indicated in vitamin C toxicity (Alhadeff et al, 1984). Again, it is highly unlikely that subjects
were vitamin C deficient before beginning the supplementation protocol.
Work Measures. Subjects were supplemented with a placebo or the antioxidant vitamin
mixture (beta-carotene, vitamin E, and vitamin C) to see if a chronic dose would cause an affect
upon the work capacity during the arm curl protocol, from acute to chronic supplementation
phase. As was noted, there is scant research investigating the affect of an acute (one day) versus
chronic (25 days) ingestion of either of the three antioxidant nutrients upon muscular fatigue
during the arm curl protocol prescribed in this study. In addition, no studies using the
intermittent arm curl protocol were found throughout the literature. Although, there were
differences seen graphically as described earlier, there were no significant differences seen in the
interaction of supplement status and training state (p=0.25). There was a significant effect for
training state (p=0.09) which was not unexpected, since the trained subjects were continuing in
their strength training program during the time of supplementation and work testing.
With the significance level determined from statistical analysis, we observed that the
interaction did not reach significance (p=0.25). However, we cannot make this determination
with any confidence because of the power being <0.10 . The power is the probability of making a
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correct decision (rejecting the null hypothesis when it is false). So, under these conditions it is
not possible to make a decision and be confident in it.
Although there is not a significant interaction, there does appear to be a trend towards an
interaction graphically (figures 1 and 2). We know that the analysis for this investigation resulted
in a low power. However, power can be increased by increasing the sample size. It may be
possible that with an increase in subjects, the interaction between supplemental status and
training may become significant. In the graph we notice a fairly even mean scores from acute
placebo to chronic vitamin states in the trained individuals. These subjects may have such an
adaptation to increased ROS via their training activites, that they may not notice any influence of
supplementated antioxidants upon work. Conversely the untrained subjects appear to benefit
from the vitamin supplementation graphically (figure 2), from the acute supplementation
compared to the chronic supplementation. Finally, it is believed that for the future a larger
sample size should be utilized and may possibly show a significant interaction between the
trained and untrained subjects.
Power, in this instance, appears to have been heavily influenced by the variability of the
results. The variance for the supplement status, training phase, and their interaction is 44524.25
(Std dev.=211.01), 614972.03 (Std dev.=784.20), and 283840.37 (Std dev.=532.77). These are
large values and show that if the scores were represented by a curve on a scale, the curve would
be extremely wide. The narrower the curve the more chance there is of detecting a difference
between the curve representing the null hypothesis and the curve representing the research
hypothesis.
Additionally, the concept fatigue is multifaceted and encompasses physiological as well
as psychological factors (Astrand, 1986). It may be possible that the influence of the antioxidant
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supplement may not be enough to make a noticeable impact upon work measures.
In summary, there were no determinations that could be made from the work measure
values because of the low power. However, we were able to evaluate the dietary status of each
subject for the prescribed antioxidants via the food diary. For the future, researchers may want to
consider a longer supplementation period or larger sample size to be able to detect significant
differences between the trained and untrained groups using the same protocol. Additionally, a
study design entailing a crossover may allow for less variability since each subject would have
the opportunity to fall under both treatments.

Note: References listed in reference list; None of the subjects are the same in this study (i.e. there
are no repeats because this data is the combined data of pilot and dissertation work)
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